syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.079415690000001	100.0
SMITH-MAGENIS SYNDROME; SMS	5.13608621	63.57002049488556
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	4.00297619	49.545367432381724
PANDAS	2.6298768100000003	32.550334218538026
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.21471485	27.411819554490574
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.992287530139443
NARCOLEPSY 1; NRCLP1	1.8373013	22.740521969602977
ISOTRETINOIN-LIKE SYNDROME	1.50301205	18.602979567696927
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.43888154	17.80922773636864
BRAIN-LUNG-THYROID SYNDROME	1.23225408	15.251772247901254
16P12.1P12.3 TRIPLICATION SYNDROME	1.22652468	15.180858703904612
TRICHOTHIODYSTROPHY	1.2191282499999998	15.089312108410645
CITRULLINEMIA TYPE II	1.18751505	14.698031337461732
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.1714063399999999	14.498651696432265
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.0969639500000001	13.577268358128011
SCHIZOPHRENIA	1.0894928	13.484796943279939
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	1.0714286	13.261213943059289
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666666999999999	13.202275274933895
PETERS PLUS SYNDROME	1.02729669	12.714987437414546
EHLERS-DANLOS SYNDROME, TYPE I	1.00728555	12.46730690248715
CHAR SYNDROME	1.0	12.377132683465131
MARFAN SYNDROME; MFS	1.0	12.377132683465131
TARDIVE DYSKINESIA	1.0	12.377132683465131
ATRESIA OF SMALL INTESTINE	1.0	12.377132683465131
KIFAFA SEIZURE DISORDER	1.0	12.377132683465131
BNAR SYNDROME	1.0	12.377132683465131
POSTERIOR MENINGOCELE	1.0	12.377132683465131
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	12.377132683465131
PLUMMER-VINSON SYNDROME	1.0	12.377132683465131
JUVENILE POLYPOSIS SYNDROME	1.0	12.377132683465131
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.95301205	11.795556591791106
CZEIZEL-LOSONCI SYNDROME	0.8678158	10.74107130140744
ISOLATED CLEFT LIP	0.8376065	10.367166787032838
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137844
7Q11.23 MICRODUPLICATION SYNDROME	0.8260391	10.223995542430123
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328383
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.7462712499999998	9.236698279105376
CRI-DU-CHAT SYNDROME	0.7208867600000001	8.922511078273285
POSTENCEPHALITIC PARKINSONISM	0.7062493799999999	8.741342283874983
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609601
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642505	8.221516573558056
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.66145674	8.186937835352298
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.6593625099999999	8.161017272772602
48,XXXY SYNDROME	0.63457391	7.854205481535261
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.6326430799999999	7.830307342436045
INHERITED CREUTZFELDT-JAKOB DISEASE	0.61823916	7.652028113434028
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.6090098199999999	7.537795347673216
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.5641516299999999	6.982579578103127
CLASSICAL EHLERS-DANLOS SYNDROME	0.56072712	6.940193963457276
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.916744619189162
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.55285233	6.842726642772851
XQ12-Q13.3 DUPLICATION SYNDROME	0.54367881	6.7291847685584285
MANGANESE POISONING	0.5408658299999999	6.694368141862494
FOCAL DERMAL HYPOPLASIA	0.5366374799999999	6.642033292880364
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.52487445	6.496440709810784
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.52487445	6.496440709810784
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.52487445	6.496440709810784
PSEUDOAMINOPTERIN SYNDROME	0.5177179500000001	6.407863759761567
MOMO SYNDROME	0.50704225	6.275729204372698
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.50671141	6.271634353795701
CUTIS LAXA	0.5059882400000001	6.262683582753
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.50297619	6.225403040253768
RESTRICTIVE DERMOPATHY	0.50297619	6.225403040253768
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.188566341732566
ZUNICH NEUROECTODERMAL SYNDROME	0.5	6.188566341732566
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.188566341732566
SEMANTIC DEMENTIA	0.5	6.188566341732566
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.188566341732566
VASCULAR EHLERS-DANLOS SYNDROME	0.49632613000000003	6.143094365280764
YOUNG-ONSET PARKINSON DISEASE	0.48612374999999997	6.016818154333632
X-LINKED ADRENOLEUKODYSTROPHY	0.46036826	5.698039037275973
LOEYS-DIETZ SYNDROME 3; LDS3	0.45728555	5.659883926581329
MUCOPOLYSACCHARIDOSIS TYPE 2	0.45332989	5.610924197910653
AUTISM	0.4498744500000001	5.568155758550901
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.4498744500000001	5.568155758550901
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.4498744500000001	5.568155758550901
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.4498744500000001	5.568155758550901
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.4498744500000001	5.568155758550901
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.4498744500000001	5.568155758550901
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.44283220000000006	5.480992895910768
16P13.2 MICRODELETION SYNDROME	0.43739893	5.413744592215678
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574125
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.06479745195534
WILLIAMS SYNDROME	0.40834412000000003	5.054129353752808
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.4	4.950853073386053
CHILDHOOD DISINTEGRATIVE DISORDER	0.39708261	4.914744150266638
11Q22.2Q22.3 MICRODELETION SYNDROME	0.39168219	4.847902435380199
MONOSOMY 22Q13.3	0.38977241	4.824264834923971
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.3888886	4.8133258012869975
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.38572324	4.774147720576065
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.37870286	4.687255545827719
CHROMOSOME 17Q12 DELETION SYNDROME	0.36537525	4.522297948504243
FRYNS MICROPHTHALMIA SYNDROME	0.3627448	4.489740519837023
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.35937319	4.448009655510124
49,XXXXY SYNDROME	0.35921185	4.446012728922974
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.4380325726253105
SCHINZEL-GIEDION SYNDROME	0.35252334999999996	4.363228276969617
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.35215683999999997	4.3586919340698005
GLOMUVENOUS MALFORMATION	0.35	4.331996439212796
KAPOSI SARCOMA	0.35	4.331996439212796
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829092
DUPLICATION/INVERSION 15Q11	0.34603715	4.282947718958127
FRYNS SYNDROME; FRNS	0.34556844999999997	4.277146556869385
POSTERIOR CORTICAL ATROPHY	0.34280516	4.242944949896494
OKAMOTO SYNDROME	0.34259226	4.2403098583481835
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.34173636	4.229716270484406
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.34004440999999996	4.208774780840617
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.33888028	4.194366189369815
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.33882751	4.193713048078108
TEMPI SYNDROME	0.33870933999999997	4.192250442308903
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.33787845	4.181966406533539
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361182
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361182
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361182
DISTAL MONOSOMY 19P13.3	0.3376065	4.178600445300271
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.33630919	4.1625434672986845
ANGELMAN SYNDROME	0.3357143	4.155180434836618
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.333333	4.125706768777483
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.333333	4.125706768777483
MAST SYNDROME	0.333333	4.125706768777483
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.333333	4.125706768777483
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.33228909	4.1127861561978865
PRADER-WILLI SYNDROME	0.32897059	4.0717126413878075
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.069538102946649
CHROMOSOME 1P36 DELETION SYNDROME	0.32527734	4.0260007961046
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.32455146999999995	4.017016606803653
GITELMAN SYNDROME	0.31578484	3.9085108641068076
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.856037638781276
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.309524	3.8310196167168615
OROFACIODIGITAL SYNDROME I; OFD1	0.3042001	3.7651250000233607
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.29911194999999996	3.702148292359988
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.29645794000000003	3.6692992584467454
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.29558179	3.658455033646127
MYOCLONUS-DYSTONIA SYNDROME	0.29335654999999994	3.6309129429135725
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.29180599999999995	3.611721579831226
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882243
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882243
2Q23.1 MICRODELETION SYNDROME	0.29056168	3.5963204660905363
DIGEORGE SYNDROME; DGS	0.28856152999999996	3.5715643441537033
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.28706146	3.552997778729218
TETRASOMY 9P	0.28326691000000004	3.506032129905176
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.27878029	3.4505006388648876
HYPERTRYPTOPHANEMIA; HYPTRP	0.27672768000000003	3.4250952125474807
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.2763158	3.4199973191378144
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.27397014	3.3909647740875175
1P21.3 MICRODELETION SYNDROME	0.27299465	3.3788910049261247
CHRISTIANSON SYNDROME	0.27117585	3.356379476001438
PLACENTAL INSUFFICIENCY	0.26894705	3.3287933226765314
PALLISTER-HALL SYNDROME	0.26761468	3.3123024024030627
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.2642857	3.271099175242461
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.2642857	3.271099175242461
LYSINURIC PROTEIN INTOLERANCE	0.2619048	3.241630460036399
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.26148974999999997	3.2364933311161264
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.26148974999999997	3.2364933311161264
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.26148974999999997	3.2364933311161264
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.26148974999999997	3.2364933311161264
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.26148974999999997	3.2364933311161264
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.26148974999999997	3.2364933311161264
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.26148974999999997	3.2364933311161264
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.26059143	3.225374705283916
21Q22.11Q22.12 MICRODELETION SYNDROME	0.25934049	3.2098916549248617
ESOPHAGEAL ATRESIA	0.25925926	3.208886260436984
WILSON DISEASE	0.25918378	3.207952034462036
WILLIAMS-BEUREN SYNDROME; WBS	0.25823091000000004	3.1961582360419434
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.25704225	3.181446033506415
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25704225	3.181446033506415
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25549451	3.1622894501669085
CHOANAL ATRESIA	0.25396799999999997	3.143395633354272
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.25	3.094283170866283
TUBERCULOSIS	0.25	3.094283170866283
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	3.094283170866283
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	3.094283170866283
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	3.094283170866283
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.25	3.094283170866283
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.25	3.094283170866283
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.25	3.094283170866283
PRADER-WILLI-LIKE SYNDROME	0.24677551	3.054373230299776
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.24333569000000002	3.0117981217525394
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268293999999999	3.003718948393407
ADNP SYNDROME	0.24249757	3.0014245993078736
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362	2.9511245509389057
SPASTIC PARAPLEGIA 16, X-LINKED	0.23803410000000003	2.9461796388892076
VELOCARDIOFACIAL SYNDROME	0.23588099	2.919530310737112
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.23442700000000002	2.9015340835866805
CONGENITAL MYASTHENIC SYNDROME	0.23392839999999998	2.8953628452307045
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.23392839999999998	2.8953628452307045
PHELAN-MCDERMID SYNDROME	0.23079489	2.8565789761957396
ADENYLOSUCCINASE DEFICIENCY	0.22853189000000002	2.8285695249330582
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.22664591	2.8052265002346966
NARCOLEPSY 7; NRCLP7	0.2261903	2.7995873548127834
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.7910378504116795
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.753540831861815
PAROXYSMAL HEMICRANIA	0.21970636999999998	2.719334892892483
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.21857585000000002	2.7053422968511724
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417217
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.21708947	2.686945174373123
PITT-HOPKINS-LIKE SYNDROME	0.21585839	2.671707933869163
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.21520014	2.663560686280272
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472004	2.6576184248789403
SCHIZOPHRENIA 10	0.2144928	2.65480584524795
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.21424836000000003	2.651780378934804
POPOV-CHANG SYNDROME; POPCHAS	0.2140845	2.649752261973291
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.211111	2.612948857939007
FAMILIAL CERVICAL ARTERY DISSECTION	0.20980392	2.596770955351104
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.20966545	2.5950570937884243
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.5914070773600706
NARCOLEPSY TYPE 1	0.2089371	2.5860422091984225
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.2083333	2.5785688964841462
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184	2.555653130406018
PEDIATRIC-ONSET GRAVES DISEASE	0.20586476999999997	2.548015573141032
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570885	2.546085730613026
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570885	2.546085730613026
MALARIA	0.20537634000000002	2.5419702102244477
PITT-HOPKINS SYNDROME	0.20466515000000002	2.5331677172312936
APNEA, OBSTRUCTIVE SLEEP	0.20368649999999996	2.52105483633062
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.20307975	2.5135450110749282
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.20301205	2.5127070791922574
COFFIN-LOWRY SYNDROME; CLS	0.20301205	2.5127070791922574
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.4754265366930266
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	2.4754265366930266
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	2.4754265366930266
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	2.4754265366930266
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	2.4754265366930266
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2	2.4754265366930266
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	2.4754265366930266
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	2.4754265366930266
ROMANO-WARD SYNDROME	0.2	2.4754265366930266
POLYARTERITIS NODOSA	0.2	2.4754265366930266
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.4754265366930266
RADIATION PROCTITIS	0.2	2.4754265366930266
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.4754265366930266
BENIGN SCHWANNOMA	0.2	2.4754265366930266
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.1993704	2.4676338939555165
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.19918384	2.4653248160820893
PROGRESSIVE NON-FLUENT APHASIA	0.19787205	2.4490886171992465
NON-DISTAL MONOSOMY 20Q	0.19709348	2.439452153005881
HEREDITARY COPROPORPHYRIA	0.19663756	2.4338091706728355
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655000000002	2.3784708866737363
WITTEVEEN-KOLK SYNDROME	0.19198088	2.3761728244483975
MUCOLIPIDOSIS TYPE II	0.19047650000000002	2.3575529135820465
GITELMAN SYNDROME	0.1870752	2.315454572185776
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.1870752	2.315454572185776
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.3113591027521445
HYPOPLASMINOGENEMIA	0.18633529999999998	2.30629673171328
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18629060000000003	2.3057434738823295
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.18587804000000002	2.3006371640224392
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.18577807	2.299399822068073
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.18551289999999998	2.2961177777943984
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.1852756	2.2931806842086124
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263564
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263564
THORACOABDOMINAL SYNDROME	0.18469819	2.286034004025853
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.18447792	2.283307693009666
MONOSOMY X	0.18447792	2.283307693009666
TURNER SYNDROME	0.18447792	2.283307693009666
MOSAIC MONOSOMY X	0.18447792	2.283307693009666
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.184019	2.27762757927857
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.1838119	2.2750642750998242
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18292109999999998	2.2640387253053933
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.2632453511003834
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.18125739000000002	2.2434467658885864
KERATODERMA HEREDITARIUM MUTILANS	0.1807515	2.2371852982353477
KOOLEN-DE VRIES SYNDROME	0.17932520000000002	2.2195317938889216
KOOLEN-DE VRIES SYNDROME; KDVS	0.17898111	2.215272946303868
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.17847085000000001	2.208957390580803
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.17847064999999998	2.208954915154266
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.17815645	2.2050660200651215
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.17592626	2.1774626625257842
INSULINOMA	0.17526791	2.169314177223625
ABLEPHARON-MACROSTOMIA SYNDROME	0.17401994	2.153867886948641
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.17395254999999998	2.1530337919771023
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.17395254999999998	2.1530337919771023
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090644
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1729891	2.141109043493218
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286091	2.1395224188545248
2Q32Q33 MICRODELETION SYNDROME	0.17227555999999997	2.132277464238258
XIA-GIBBS SYNDROME	0.17142839999999998	2.1217920525141336
AURICULOCONDYLAR SYNDROME	0.17142839999999998	2.1217920525141336
MELAS	0.171174	2.1186433099594604
TRIGEMINAL NEURALGIA	0.17111144	2.117868996538783
TRISOMY 13	0.16964268999999998	2.099690082909943
MCLEOD SYNDROME; MCLDS	0.16835655	2.0837713574804315
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.167857	2.0775883608484067
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.0628595729550834
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.0628595729550834
CEREBROOCULONASAL SYNDROME	0.166667	2.0628595729550834
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	2.0628595729550834
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.166667	2.0628595729550834
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.166667	2.0628595729550834
PARAGANGLIOMAS 4	0.166667	2.0628595729550834
SOLITARY BONE CYST	0.166667	2.0628595729550834
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.166667	2.0628595729550834
PARAGANGLIOMAS 3	0.166667	2.0628595729550834
DERMATOLEUKODYSTROPHY	0.166667	2.0628595729550834
ACUTE ADRENAL INSUFFICIENCY	0.166667	2.0628595729550834
PARAGANGLIOMAS 1	0.166667	2.0628595729550834
ADDISON DISEASE	0.166667	2.0628595729550834
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.0628595729550834
PERRY SYNDROME	0.16532722	2.0462769381284303
CHROMOSOME 16P13.2 DELETION SYNDROME	0.16485985	2.040492237626159
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515095
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.1637426	2.0266638861355575
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16208779999999998	2.0061822069709594
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.16151198	1.9990552064291667
MYOTONIC DYSTROPHY 1	0.16025640000000002	1.9835147261744617
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.9815591392104739
SPINOCEREBELLAR ATAXIA TYPE 7	0.15945064999999997	1.9735418515147591
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.15908541999999998	1.9690213513447772
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.1589598	1.9674665359370809
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.944976048137956
EEC SYNDROME	0.15475539	1.9154279955113929
CHRONIC HICCUP	0.15454781999999997	1.9128588740802859
LENNOX-GASTAUT SYNDROME	0.15430775	1.9098874958369667
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.15238005000000002	1.8860280971630512
DRAVET SYNDROME	0.15188942000000002	1.8799555045545626
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.1508941	1.8676362968520561
GOLDENHAR SYNDROME	0.14989924999999998	1.8553229064019103
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.1497326	1.853260257240211
TRISOMY 18	0.14878518	1.8415339141932423
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.14810843999999998	1.8331578134210342
TUBEROUS SCLEROSIS COMPLEX	0.1475979	1.826838792100818
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454777
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.14690622	1.8182777769663192
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001187
TONNE-KALSCHEUER SYNDROME; TOKAS	0.14410771000000003	1.7836402473803155
3Q27.3 MICRODELETION SYNDROME	0.1432077	1.7725007041938694
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617782
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.14285699999999998	1.7681600437617782
PROLIDASE DEFICIENCY	0.14285699999999998	1.7681600437617782
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617782
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.14285699999999998	1.7681600437617782
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617782
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617782
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.14285699999999998	1.7681600437617782
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617782
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	1.7681600437617782
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617782
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617782
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617782
8Q22.1 MICRODELETION SYNDROME	0.14285699999999998	1.7681600437617782
HUNTINGTON DISEASE-LIKE 1	0.14042569	1.7380673972971425
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.13952592000000003	1.7269308246225417
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525	1.7194962523335644
SYDENHAM CHOREA	0.13666975	1.6915796295660086
ADRENOCORTICAL CARCINOMA	0.13663752	1.6911807145796205
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.13552544	1.6774163528649928
SMITH-MAGENIS SYNDROME	0.13547802	1.676829429233143
17Q24.2 MICRODELETION SYNDROME	0.13526925	1.6742454552428159
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.13486353	1.6692238049704804
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.1346876	1.6670462960174781
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.13339424	1.6510382076899917
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.13310393	1.647445002300655
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13293112	1.6453061100016257
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13278163	1.6434558524367742
DISTAL MONOSOMY 12Q	0.1325647	1.6407708810437502
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1322581	1.6369760521629997
FG SYNDROME TYPE 1	0.13146738	1.6271892058075301
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.623272090855867
BRUNNER SYNDROME; BRNRS	0.13089283000000002	1.6200779242242453
8Q24.3 MICRODELETION SYNDROME	0.13081235000000002	1.6190818125858801
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.13053441	1.6156417123278377
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.608112702516486
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786	1.6042974513668078
HOLOPROSENCEPHALY	0.12914219	1.5984100206632637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.12852298	1.5907459763343357
USHER SYNDROME	0.12682065	1.5696760120532924
LUSCAN-LUMISH SYNDROME; LLS	0.12651676	1.5659147252021142
ROLANDIC EPILEPSY	0.12642464999999997	1.5647746675106395
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.12602785	1.5598634212618412
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.12510796	1.5484778206776482
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.5471415854331414
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.5471415854331414
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.5471415854331414
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.5471415854331414
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.12445218	1.5403611446064855
HSD10 DISEASE	0.12423601000000001	1.537685579834301
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1238095	1.5324066089734762
CARTILAGE-HAIR HYPOPLASIA	0.1237692	1.5319078105263326
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.1229513	1.5217845537045265
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.1229513	1.5217845537045265
JACOBSEN SYNDROME	0.12246513	1.5157671631078062
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.12237621	1.5146665884695925
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.12148964000000001	1.5036933939464128
CHILDHOOD APRAXIA OF SPEECH	0.12099711	1.4975972847858259
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.12012195	1.4867653133465644
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511912
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.11988292999999998	1.4838069310925623
MOHR-TRANEBJAERG SYNDROME	0.11965903	1.4810356910847347
KUFOR-RAKEB SYNDROME	0.1188844	1.471447992794142
APLASIA CUTIS CONGENITA	0.11846393999999999	1.4662439035860522
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.11846393999999999	1.4662439035860522
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.11709924	1.4493528306129273
STEINERT MYOTONIC DYSTROPHY	0.11660550999999998	1.44324186889312
POTOCKI-LUPSKI SYNDROME	0.11618595000000001	1.4380489191044459
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11409354000000002	1.4121508829062366
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.11408718999999999	1.4120722881136962
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.11408718999999999	1.4120722881136962
GM2-GANGLIOSIDOSIS, AB VARIANT	0.1136364	1.406492800471317
WIEDEMANN-STEINER SYNDROME	0.11290435000000001	1.3974321204903866
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.11278827000000001	1.39599538292849
CONGENITAL PULMONARY VENOUS RETURN ANOMALY	0.11265820000000001	1.3943854892803516
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.1125	1.3924274268898273
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232785	1.3902967034983689
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189494999999999	1.3849386427596966
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189494999999999	1.3849386427596966
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.11189494999999999	1.3849386427596966
POLAND SYNDROME	0.11174812	1.3831213083677836
MEACHAM SYNDROME	0.11174812	1.3831213083677836
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.11163829	1.3817619278851585
SOMATOMAMMOTROPINOMA	0.11143636999999999	1.3792627372537132
ACROMEGALY	0.11143636999999999	1.3792627372537132
MUCKLE-WELLS SYNDROME	0.11111099999999999	1.3752355895924941
TRISOMY XQ28	0.11111099999999999	1.3752355895924941
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924941
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.11111099999999999	1.3752355895924941
ULNAR HEMIMELIA	0.11111099999999999	1.3752355895924941
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.11111099999999999	1.3752355895924941
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11111099999999999	1.3752355895924941
DIABETIC EMBRYOPATHY	0.11111099999999999	1.3752355895924941
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.11111099999999999	1.3752355895924941
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.11111099999999999	1.3752355895924941
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.11111099999999999	1.3752355895924941
ULNAR-MAMMARY SYNDROME	0.11111099999999999	1.3752355895924941
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.11111099999999999	1.3752355895924941
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.11111099999999999	1.3752355895924941
RING CHROMOSOME 22 SYNDROME	0.11077841000000001	1.3711190790333008
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.11035434	1.3658703083762234
MYHRE SYNDROME	0.11011852	1.3629515329468087
SAGLIKER SYNDROME	0.10937055	1.3536938090135573
CONGENITAL UNILATERAL PULMONARY HYPOPLASIA	0.10877193	1.3462846098465815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.10782433	1.3345560389157298
MEND SYNDROME	0.10672514	1.3209512184413919
DEMENTIA, LEWY BODY; DLB	0.1055556	1.306475666682772
NAGER SYNDROME	0.10549451	1.305719547647139
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.10546448	1.3053478623526547
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.1051948	1.3020099972105779
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.10473934	1.2963727083585668
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.294770612304019
HUNTINGTON DISEASE-LIKE 1	0.10444444	1.2927226919302128
48,XYYY SYNDROME	0.10438974000000001	1.2920456627724275
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106442
HUNTINGTON DISEASE-LIKE 2	0.10330205999999999	1.2785833030952758
HOLT-ORAM SYNDROME	0.10297619000000001	1.2745499668677154
MYASTHENIA GRAVIS	0.1029573	1.2743161628313247
NIEMANN-PICK DISEASE, TYPE C2	0.1029573	1.2743161628313247
22Q11.2 DELETION SYNDROME	0.10259352000000001	1.2698136095037338
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.269466059617982
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.10250000000000001	1.2686561000551762
RAMOS-ARROYO SYNDROME	0.10218259000000002	1.2647274743701176
CHIARI MALFORMATION TYPE I	0.10083089	1.2479973041218775
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10059670000000001	1.2450987034187369
MOWAT-WILSON SYNDROME; MOWS	0.10059529	1.2450812516616532
SPINOCEREBELLAR ATAXIA TYPE 29	0.1	1.2377132683465133
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.1	1.2377132683465133
PARTIAL ATRIOVENTRICULAR CANAL	0.1	1.2377132683465133
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.1	1.2377132683465133
DESMOSTEROLOSIS	0.1	1.2377132683465133
METAPHYSEAL ANADYSPLASIA	0.1	1.2377132683465133
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	1.2377132683465133
49,XYYYY SYNDROME	0.0996504	1.2333862227603738
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.09950135	1.2315414111339031
FOCAL DERMAL HYPOPLASIA; FDH	0.09941058	1.230417938800225
VACTERL WITH HYDROCEPHALUS	0.09878436	1.2226671307711856
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0987216	1.2218903419239713
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0981997	1.2154307163764708
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059284
OCCIPITAL HORN SYNDROME	0.09777015	1.2101141190322884
ARTERIAL TORTUOSITY SYNDROME	0.09777015	1.2101141190322884
SCHIZOPHRENIA 1; SCZD1	0.09730530000000001	1.20436060890438
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.09565324	1.183912843083334
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.09565324	1.183912843083334
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09404759	1.1640394999901285
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302322
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166453999999999	1.1345441739487967
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.1319147758815218
RAYNAUD-CLAES SYNDROME; MRXSRC	0.09117673	1.1285064848544757
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09114580000000001	1.1281236601405764
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0910714	1.1272028014689264
LAFORA DISEASE	0.09016666000000001	1.1160047144448884
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.08897250000000001	1.1012244376796017
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.08897250000000001	1.1012244376796017
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.096126544269936
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0885306	1.0957549827467783
15Q13.3 MICRODELETION SYNDROME	0.08845574	1.094828430594094
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.08837385	1.0938148671986452
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.0900867510630585
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08787875000000002	1.0876869488070615
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.08736964000000001	1.0813856267865827
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.08731369	1.0806931262129427
47,XYY SYNDROME	0.08701528	1.0769996660488697
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100152
HYDROXYKYNURENINURIA	0.0860457	1.0649990457416356
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.08571430000000001	1.0608972639703353
NASU-HAKOLA DISEASE	0.08565881	1.06021045687773
HUNTINGTON DISEASE-LIKE 2	0.0851393	1.053780412677343
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534554
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853621
3Q29 MICRODELETION SYNDROME	0.08411931999999998	1.041155984882862
RETT SYNDROME, CONGENITAL VARIANT	0.08399551	1.0396235720853222
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.08391391000000001	1.0386135980583517
SMITH-LEMLI-OPITZ SYNDROME	0.08375535	1.0366510799000612
49,XXXYY SYNDROME	0.08363451000000001	1.0351554271865915
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	1.031427311051005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08333330000000001	1.031427311051005
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.08333330000000001	1.031427311051005
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.031427311051005
SALT-AND-PEPPER SYNDROME	0.08307881	1.0282774545543898
PHENYLKETONURIA	0.08224078	1.0179050460516654
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.08222571000000001	1.017718522662126
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.015379120813624
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08184921	1.0130585322068013
NORRIE DISEASE	0.08182004999999999	1.0126976150177511
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.08122631	1.0053488162582704
CORNELIA DE LANGE SYNDROME 1	0.08005641	0.9908688087318848
CUSHING DISEASE	0.07949597	0.9839321684907636
GLASS SYNDROME	0.07917999	0.9800212421054423
RABIES	0.07913175	0.9794241692247919
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.07878154000000001	0.9750895735877156
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.07854884000000001	0.9722094148122733
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.07851787	0.9718260950130665
CRANIOPHARYNGIOMA	0.07769854000000001	0.9616851388915229
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0776316	0.9608566136296917
1Q21.1 MICRODELETION SYNDROME	0.07714684999999999	0.9548567985613818
17P11.2 MICRODUPLICATION SYNDROME	0.07709395	0.9542020482424265
EPISODIC ATAXIA, TYPE 6	0.07684937	0.9511748491307047
EPISODIC ATAXIA TYPE 6	0.07684937	0.9511748491307047
PRIMROSE SYNDROME; PRIMS	0.07586609	0.9390046621057071
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.07574086	0.9374546737797567
FAMILIAL THYROID DYSHORMONOGENESIS	0.07570210000000001	0.9369749361169459
THYROID ECTOPIA	0.07570210000000001	0.9369749361169459
THYROID HEMIAGENESIS	0.07570210000000001	0.9369749361169459
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07570210000000001	0.9369749361169459
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.07570210000000001	0.9369749361169459
FRAXE INTELLECTUAL DISABILITY	0.07411655	0.9173503733906777
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.07337811	0.9082106035318995
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0731092	0.904882268781989
BILATERAL POLYMICROGYRIA	0.0731092	0.904882268781989
PRADER-WILLI SYNDROME; PWS	0.07243153	0.8964946572763852
ACHONDROGENESIS TYPE 1A	0.07226801	0.8944707485399849
ACHONDROGENESIS TYPE 2	0.07226801	0.8944707485399849
ACHONDROGENESIS TYPE 1B	0.07226801	0.8944707485399849
GLIOBLASTOMA	0.07204304	0.8916862650001859
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0717884	0.8885345519336683
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.07165412	0.8868725505569325
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.8840812595941575
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.07142860000000001	0.8840812595941575
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07142860000000001	0.8840812595941575
ALZHEIMER DISEASE 4	0.07142860000000001	0.8840812595941575
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.07142860000000001	0.8840812595941575
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.8840812595941575
ATHYREOSIS	0.07142860000000001	0.8840812595941575
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524645
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471941
KLEEFSTRA SYNDROME	0.07028443	0.8699197156917171
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07014978	0.8682531347758886
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.06978555	0.8637450117385901
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875289
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.069264	0.8572897181875289
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.06902731999999999	0.8543602984240062
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.06890753999999999	0.8528777654711807
PSEUDOTRISOMY 13 SYNDROME	0.06887165	0.8524335501791713
CORNELIA DE LANGE SYNDROME	0.06831264	0.8455146092377874
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.06795380000000001	0.841073198945653
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.06764250000000001	0.8372201975412903
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064401
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.06759543	0.8366376059058794
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.06744533	0.8347797982900912
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.06744164999999999	0.834734250441816
CENTRAL DIABETES INSIPIDUS	0.06741319	0.8343819972456448
TRIPLOIDY	0.06737196000000001	0.8338716880651057
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726273
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002703
HEPATOCELLULAR CARCINOMA	0.0666667	0.8251425914687648
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.06658700000000001	0.8241561339938928
SUSAC SYNDROME	0.06646764	0.8226787994367943
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.06586575	0.8152291270459435
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06567676	0.8128899727400953
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.06565465000000001	0.812616314336464
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06553491	0.8111342764689458
POLYDACTYLY-MYOPIA SYNDROME	0.06551205	0.8108513352158019
PERLMAN SYNDROME	0.06551205	0.8108513352158019
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.06551205	0.8108513352158019
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.06551205	0.8108513352158019
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.0652947	0.8081611654270506
13Q12.3 MICRODELETION SYNDROME	0.06512113	0.8060128665071817
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765597
15Q24 MICRODELETION SYNDROME	0.0646014	0.7995800993376043
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.79823594272818
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394994
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.7957008584119527
NOCARDIOSIS	0.06419984000000001	0.7946099379372321
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06398344	0.7919315264245302
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.7904451565605729
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06356284	0.7867257044178647
PAGOD SYNDROME	0.06348569000000001	0.7857708086313355
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.7773084392443236
SCHAAF-YANG SYNDROME; SHFYNG	0.0627914	0.7771774891805324
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0625	0.7735707927165707
HADDAD SYNDROME	0.0625	0.7735707927165707
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0625	0.7735707927165707
DYSTONIA 12; DYT12	0.06247675	0.7732830243816802
RAPID-ONSET DYSTONIA-PARKINSONISM	0.06247675	0.7732830243816802
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0622606	0.7706077071521491
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701812
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0616699	0.7632965348760263
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.06143066	0.7603354296528341
MARFAN SYNDROME	0.06117741000000001	0.7572009208007466
BENIGN OCCIPITAL EPILEPSY	0.060931940000000004	0.7541627060409365
FRASER SYNDROME	0.06086301	0.7533095502850652
PERRY SYNDROME	0.060733920000000004	0.7517117862269567
RHEUMATOID ARTHRITIS	0.0607197	0.7515357834001977
HOLT-ORAM SYNDROME	0.0604441	0.7481246456326348
RING CHROMOSOME 12 SYNDROME	0.0604441	0.7481246456326348
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215691
AICARDI SYNDROME; AIC	0.0600359	0.7430723000712444
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.05998167	0.74240108816582
SCHISIS ASSOCIATION	0.059706859999999994	0.7389997283330768
SPINOCEREBELLAR ATAXIA 12	0.05937055	0.7348371748403008
ALG11-CDG	0.0588235	0.7280662644058111
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0588235	0.7280662644058111
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	0.7280662644058111
BUTYRYLCHOLINESTERASE	0.0588235	0.7280662644058111
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	0.7280662644058111
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.0588235	0.7280662644058111
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	0.7280662644058111
16P13.11 MICRODELETION SYNDROME	0.05818969	0.7202215139397041
TURNPENNY-FRY SYNDROME; TPFS	0.05800918	0.7179873177190118
INIENCEPHALY	0.0580085	0.717978901268787
KLEEFSTRA SYNDROME	0.05788427	0.7164412900755203
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.05736720000000001	0.710041446078881
N-ACETYLASPARTATE DEFICIENCY; NACED	0.05710565	0.7068042070255206
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267632
ALEXANDER DISEASE	0.05690614	0.7043348452838425
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.056905250000000004	0.7043238296357542
GANGLIOCYTOMA	0.05686524	0.7038286205570887
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.05677989	0.7027722322825549
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363914
OTOPALATODIGITAL SYNDROME TYPE 2	0.05640026	0.6980735014019311
HALLERMANN-STREIFF SYNDROME; HSS	0.0563492	0.6974415250071134
2Q37 MICRODELETION SYNDROME	0.05628048	0.6965909684491057
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.05552759	0.6872723490230516
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504071
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091226
9P13 MICRODELETION SYNDROME	0.05519248	0.6831246480894956
MENINGIOMA	0.05517834	0.6829496354333514
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.05489349	0.6794240091884663
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05482505	0.67857691822761
FILIPPI SYNDROME	0.0546099	0.6759139781307625
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307625
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.0546099	0.6759139781307625
MIETENS SYNDROME	0.0546099	0.6759139781307625
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0546099	0.6759139781307625
HYPERTRICHOSIS CUBITI	0.0546099	0.6759139781307625
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0546099	0.6759139781307625
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307625
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.0546099	0.6759139781307625
BECKWITH-WIEDEMANN SYNDROME	0.0545534	0.6752146701341467
NEUROFIBROMATOSIS TYPE 1	0.054319120000000005	0.6723149554890646
NEUROCUTANEOUS MELANOCYTOSIS	0.054226430000000006	0.6711677190606341
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.05403793999999999	0.6688347533211277
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.05394997	0.6677459369589633
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.05374004	0.6651476054947235
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.05363528	0.6638509770748038
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.05360379	0.6634612211666013
1P36 DELETION SYNDROME	0.05301575	0.6561829720634165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.053012050000000005	0.6561371766724878
SMITH-FINEMAN-MYERS SYNDROME	0.053012050000000005	0.6561371766724878
LATHOSTEROLOSIS	0.052807440000000004	0.6536046915541239
LATERAL MENINGOCELE SYNDROME	0.052740050000000004	0.6527705965825853
LATERAL MENINGOCELE SYNDROME	0.052740050000000004	0.6527705965825853
ATRIAL SEPTAL DEFECT WITH ATRIOVENTRICULAR CONDUCTION DEFECTS	0.0526316	0.6514282965430634
PRIMARY PULMONARY HYPOPLASIA	0.0526316	0.6514282965430634
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0526316	0.6514282965430634
ATRIAL SEPTAL DEFECT 1	0.0526316	0.6514282965430634
PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHICABNORMALITIES	0.0526316	0.6514282965430634
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.0526316	0.6514282965430634
DOHLE BODIES AND LEUKEMIA	0.0526316	0.6514282965430634
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0526316	0.6514282965430634
MONOSOMY 18Q	0.0526316	0.6514282965430634
IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS	0.0526316	0.6514282965430634
CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA	0.0526316	0.6514282965430634
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0526316	0.6514282965430634
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.05260747	0.6511296363314114
CRANIORACHISCHISIS	0.05251399	0.6499726219681612
PARKINSON DISEASE, LATE-ONSET; PD	0.052499420000000005	0.649792287144963
OCULOCEREBRORENAL SYNDROME OF LOWE	0.05233408	0.6477458520270788
RETT SYNDROME; RTT	0.05216591	0.6456643896237005
1Q21.1 MICRODUPLICATION SYNDROME	0.05199953	0.6436050822878256
HARTNUP DISEASE	0.05131218	0.6350976601378459
WAARDENBURG SYNDROME TYPE 1	0.05094901	0.6306026568611918
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.05083084	0.6291400510919868
AMYOTROPHIC LATERAL SCLEROSIS	0.050723950000000004	0.6278170593794512
SIRENOMELIA	0.0505051	0.6251083238916748
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.05038388	0.6236079678677852
TRANSKETOLASE DEFICIENCY	0.05038388	0.6236079678677852
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.050370040000000005	0.6234366683514461
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726195
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.05	0.6188566341732566
LOEYS-DIETZ SYNDROME 5	0.049976049999999994	0.6185602018454874
LYME DISEASE	0.04992179	0.6178886186260828
OROMANDIBULAR DYSTONIA	0.04989894	0.6176058011442656
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.04977471000000001	0.6160681899509988
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.049554930000000004	0.6133479437298268
ERYTHERMALGIA, PRIMARY	0.0494995	0.6126618792651823
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.04927881	0.6099303698532683
BAKER-GORDON SYNDROME; BAGOS	0.0492035	0.6089982479908765
USHER SYNDROME TYPE 2	0.04886335	0.6047881663085959
USHER SYNDROME TYPE 1	0.04886335	0.6047881663085959
USHER SYNDROME TYPE 3	0.04886335	0.6047881663085959
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0488247	0.60430979013038
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.04875074	0.6033943773971109
MECKEL SYNDROME, TYPE 4; MKS4	0.04843069	0.5994330760817679
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04843069	0.5994330760817679
ARTERIAL TORTUOSITY SYNDROME	0.04831558	0.5980083443385742
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.047946039999999995	0.5934344987267265
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.047782460000000006	0.5914098473623653
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.047619	0.5893866812539261
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.04722509	0.5845112049185823
MICROPHTHALMIA, SYNDROMIC 1	0.04704105	0.5822333174195174
FIBULAR HEMIMELIA	0.04703554	0.5821651194184315
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.046811109999999996	0.5793873195302813
JOUBERT SYNDROME 1	0.04680284	0.5792849606429892
COFFIN-SIRIS SYNDROME 1; CSS1	0.04661342	0.5769404841700873
FETAL HYDANTOIN SYNDROME	0.0465368	0.5759921482638801
WHITE FORELOCK WITH MALFORMATIONS	0.04645449	0.5749733864727041
DESANTO-SHINAWI SYNDROME	0.04618581	0.5716478984633108
CHOREOACANTHOCYTOSIS	0.04600717	0.5694368474807365
LYNCH SYNDROME	0.04584316	0.5674068739493214
FAMILIAL COLORECTAL CANCER TYPE X	0.04584316	0.5674068739493214
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.5625963775605658
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0454545	0.5625963775605658
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.0454545	0.5625963775605658
MICROTRIPLICATION 11Q24.1	0.0454545	0.5625963775605658
HUMERO-RADIAL SYNOSTOSIS	0.0454545	0.5625963775605658
PHOCOMELIA, SCHINZEL TYPE	0.0454545	0.5625963775605658
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0454545	0.5625963775605658
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0454545	0.5625963775605658
WILDERVANCK SYNDROME	0.0454545	0.5625963775605658
LITHIUM TRANSPORT	0.0454545	0.5625963775605658
ACROMELIC FRONTONASAL DYSPLASIA	0.0454545	0.5625963775605658
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0454545	0.5625963775605658
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.5625963775605658
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.0454545	0.5625963775605658
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0454545	0.5625963775605658
MUSCLE-EYE-BRAIN DISEASE	0.0454545	0.5625963775605658
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0454545	0.5625963775605658
TYPHOID	0.04537634	0.5616289808700262
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045321700000000006	0.5609526943402017
16P13.11 MICRODUPLICATION SYNDROME	0.04522226	0.5597219122661579
SILVER-RUSSELL SYNDROME	0.04508845	0.5580657281417835
MARSHALL-SMITH SYNDROME; MRSHSS	0.045080350000000005	0.5579654733670474
SILVER-RUSSELL SYNDROME; SRS	0.0448255	0.5548111611026663
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.04471564	0.5534514093060607
TRISOMY 18P	0.04447549	0.5504790408921266
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.04415663	0.546532468364677
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.04385976	0.5428580689849366
HEREDITARY HYPEREKPLEXIA	0.043777979999999994	0.5418458670740828
CAUDAL DUPLICATION	0.04374206	0.5414012804680928
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.04374206	0.5414012804680928
CLOACAL EXSTROPHY	0.04374206	0.5414012804680928
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	0.538136687951502
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	0.538136687951502
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	0.538136687951502
LICHTENSTEIN SYNDROME	0.043478300000000004	0.538136687951502
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	0.538136687951502
JUVENILE XANTHOGRANULOMA	0.043478300000000004	0.538136687951502
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	0.538136687951502
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	0.538136687951502
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	0.538136687951502
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	0.538136687951502
SLC35A2-CDG	0.043478300000000004	0.538136687951502
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	0.538136687951502
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	0.538136687951502
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	0.538136687951502
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.043441509999999996	0.5376813332400773
KAGAMI-OGATA SYNDROME	0.04340197	0.5371919414137731
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.04317222	0.534348295179747
ISOLATED HEMIHYPERPLASIA	0.042989360000000004	0.5320850126972486
ACALVARIA	0.04253157	0.526418885126085
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.04251984	0.5262737013597081
48,XXYY SYNDROME	0.04243204	0.5251869891100998
FANCONI ANEMIA	0.04238043	0.5245482052923061
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.04237233	0.5244479505175701
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.5228274125353239
WOLFRAM SYNDROME	0.04214738	0.5216637145204246
OGDEN SYNDROME	0.04198156	0.5196113383788524
LATHOSTEROLOSIS	0.04183574	0.5178065048909496
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0417293	0.5164890828881215
CHROMOSOME 10Q26 DELETION SYNDROME	0.04138427	0.5122186007983456
CHARGE SYNDROME	0.04129393	0.5111004506317213
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0412597	0.5106767813799663
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.041229600000000005	0.510304229686194
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04108196	0.5084768698168072
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.040935700000000005	0.5066665903905236
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.040866509999999995	0.5058102165801546
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.04083021	0.5053609266637448
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264551
GALLOWAY-MOWAT SYNDROME	0.040661459999999996	0.5032722855234101
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.0406015	0.5025301526477095
WILSON DISEASE	0.0406015	0.5025301526477095
TRISOMY 20P	0.04055786	0.5019900145774031
WHITE-SUTTON SYNDROME; WHSUS	0.04025574	0.49825063525107455
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.04019134	0.49745354790625945
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.04006544	0.4958952669014112
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.49508530733860523
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.04	0.49508530733860523
MERCURY POISONING	0.04	0.49508530733860523
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.04	0.49508530733860523
BUERGER DISEASE	0.04	0.49508530733860523
ISOLATED SPINA BIFIDA	0.03997731	0.4948044701980175
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.03997731	0.4948044701980175
TRISOMY 8Q	0.03997731	0.4948044701980175
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.039973369999999994	0.4947557042952445
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.49469790308561273
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	0.49469790308561273
COSTELLO SYNDROME; CSTLO	0.03995095	0.4944782089804813
ROSSELLI-GULIENETTI SYNDROME	0.039721099999999995	0.49163332503318674
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.4906171624398743
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.03961949	0.49037568458121994
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03954365	0.48943700283850594
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.03950779	0.4889931588604769
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.039504479999999995	0.4889521905512946
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03949072	0.48878188120557015
SIALURIA	0.03945568	0.4883481864763415
MAN1B1-CDG	0.03943095	0.4880420999850794
ATYPICAL TERATOID RHABDOID TUMOR	0.03924263	0.4857112383581293
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.03924263	0.4857112383581293
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.03921476	0.4853662876702411
SPINOCEREBELLAR ATAXIA TYPE 10	0.039157460000000005	0.48465707796747864
VACTERL/VATER ASSOCIATION	0.03909275	0.48385615371153157
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.48233079587962124
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.48233079587962124
MYOPATHY AND DIABETES MELLITUS	0.038888900000000004	0.4813330752140072
ACRORENAL-MANDIBULAR SYNDROME	0.038852170000000005	0.4808784631305435
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.038364	0.4748363182684563
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.03829731	0.474010887289796
248100 MACROSOMIA ADIPOSA CONGENITA	0.0380987	0.471552664967533
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.03785723	0.46856395873845663
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.037212129999999996	0.46057947044435327
DUBOWITZ SYNDROME	0.03714035	0.4596910398603342
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.03680355	0.4555224215725431
PITUITARY APOPLEXY	0.03680355	0.4555224215725431
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.0367747	0.4551653412946252
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0367747	0.4551653412946252
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.03676474	0.45504206505309786
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.03669735	0.45420797008155905
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0366251	0.45331372224517874
XP22.13P22.2 DUPLICATION SYNDROME	0.03659392	0.45292780324810833
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0365316	0.45215646033927476
HYPERPROLINEMIA, TYPE I	0.036450750000000004	0.45115576916181666
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.03630305	0.44932766666446894
CYCLIC VOMITING SYNDROME	0.036199550000000004	0.4480466334317303
SAETHRE-CHOTZEN SYNDROME	0.03613173	0.44720721629313764
THUMBS, CONGENITAL CLASPED	0.0361093	0.44692959720704745
17Q21.31 MICRODUPLICATION SYNDROME	0.03598867	0.4454365436914411
CLASSIC HOMOCYSTINURIA	0.035857700000000006	0.4438155106238877
MUCOPOLYSACCHARIDOSIS, TYPE II	0.03585695	0.443806227774375
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.03585695	0.443806227774375
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.03579522	0.4430421873738248
4Q21 MICRODELETION SYNDROME	0.03572607	0.4421863086487631
SIMPSON-GOLABI-BEHMEL SYNDROME	0.035645869999999996	0.44119366260754916
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.03561658	0.4408311363912506
PELVIS-SHOULDER DYSPLASIA	0.035590300000000005	0.4405058653443292
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.0355392	0.439873393864204
HURLER SYNDROME	0.03550032	0.4393921709454709
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.4393830118672852
CUSHING SYNDROME	0.035376540000000005	0.43786012946191155
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.03531276	0.43707071593936014
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.03531276	0.43707071593936014
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.03523429	0.43609948233768864
8P INVERTED DUPLICATION/DELETION SYNDROME	0.03523403	0.436096264283191
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.03523403	0.436096264283191
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.03513074	0.4348178302483159
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.035110180000000005	0.4345633564003438
SMITH-MAGENIS SYNDROME	0.03502418	0.4334989229895658
COFFIN-LOWRY SYNDROME	0.0349178	0.43218224361469876
HELSMOORTEL-VAN DER AA SYNDROME	0.03474521	0.4300460742848595
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.034604590000000005	0.4283056018869107
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03455964	0.42774924977278894
AMISH LETHAL MICROCEPHALY	0.03448921	0.42687752831789244
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.03448921	0.42687752831789244
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0344828	0.4267981908973914
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.0344828	0.4267981908973914
ISOLATED ANORECTAL MALFORMATION	0.0344828	0.4267981908973914
CEREBROCOSTOMANDIBULAR SYNDROME	0.0344828	0.4267981908973914
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.0344828	0.4267981908973914
DIAPHANOSPONDYLODYSOSTOSIS	0.0344828	0.4267981908973914
HEMIHYPERPLASIA, ISOLATED	0.0344828	0.4267981908973914
WAARDENBURG SYNDROME	0.0344828	0.4267981908973914
PHAVER SYNDROME	0.0344828	0.4267981908973914
LUMBAR SYNDROME	0.0344828	0.4267981908973914
TIBIAL HEMIMELIA	0.0344828	0.4267981908973914
CHIARI MALFORMATION TYPE II	0.0344828	0.4267981908973914
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03437055	0.4254088577536725
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.03436482	0.4253379367833962
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.03417805	0.42302625971210545
MYOCLONIC-ASTASTIC EPILEPSY	0.03417805	0.42302625971210545
15Q11Q13 MICRODUPLICATION SYNDROME	0.03413024	0.422434508998509
ADIPOSIS DOLOROSA	0.034041470000000004	0.42133579093019785
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.4206264574561084
CEREBROFACIOARTICULAR SYNDROME	0.0338018	0.41836936353995163
DISTAL MONOSOMY 10Q	0.03375586	0.4178007580644733
DISTAL MONOSOMY 15Q	0.03360602	0.4159461685031829
22Q11.2 MICRODUPLICATION SYNDROME	0.033561839999999996	0.4153993467812273
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.41287701091166407
NEU-LAXOVA SYNDROME	0.03327231	0.4118157955553837
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.033231	0.4113044962042297
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.033231	0.4113044962042297
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.03319663	0.410879094153899
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0331548	0.4103613586937497
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	0.41034650613452955
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03302721	0.40878216033466647
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.4086414323360554
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.032895030000000006	0.4071461509365661
HURLER-SCHEIE SYNDROME	0.032844899999999996	0.4065256852751439
ACROCALLOSAL SYNDROME; ACLS	0.0327912	0.40586103325004186
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534613
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.03251714	0.40246895626681134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.03251714	0.40246895626681134
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.03250586	0.4023293422101419
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.03231579	0.39997682060099565
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	0.3992627838164865
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0322581	0.3992627838164865
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	0.3992627838164865
NETHERTON SYNDROME; NETH	0.0322581	0.3992627838164865
HERNIA, HIATUS	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.3992627838164865
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.0322581	0.3992627838164865
PRIMARY BILIARY CHOLANGITIS	0.0322581	0.3992627838164865
AICARDI SYNDROME	0.0322581	0.3992627838164865
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	0.3992627838164865
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	0.3992627838164865
GASTROCUTANEOUS SYNDROME	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.3992627838164865
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	0.3992627838164865
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	0.3992627838164865
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.3992627838164865
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	0.3992627838164865
HYPER-BETA-ALANINEMIA	0.0322581	0.3992627838164865
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	0.3992627838164865
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.0322581	0.3992627838164865
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.3992627838164865
GASTROCUTANEOUS SYNDROME	0.0322581	0.3992627838164865
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	0.3992627838164865
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	0.3992627838164865
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.3992627838164865
137210 GASTRIC VOLVULUS, INTRATHORACIC	0.0322581	0.3992627838164865
SANDIFER SYNDROME	0.0322581	0.3992627838164865
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0322581	0.3992627838164865
ROWLEY-ROSENBERG SYNDROME	0.0322581	0.3992627838164865
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	0.3992627838164865
THROMBOCYTOPENIA 1	0.0322581	0.3992627838164865
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.3992627838164865
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.0322581	0.3992627838164865
ESOPHAGEAL RING, LOWER	0.0322581	0.3992627838164865
DESMOID TUMOR	0.0322581	0.3992627838164865
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	0.3992627838164865
INFANTILE MYOFIBROMATOSIS	0.0322581	0.3992627838164865
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0322581	0.3992627838164865
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	0.3992627838164865
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.3992627838164865
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.0322581	0.3992627838164865
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0322498	0.3991600536152138
TYSHCHENKO SYNDROME	0.03221285	0.3987027185625598
ALSTRÖM SYNDROME	0.03216114	0.39806269703149777
GABRIELE-DE VRIES SYNDROME	0.03213874	0.3977854492593882
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.03210344	0.39734853647566176
WHIPPLE DISEASE	0.03209902	0.3972938295492009
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03204225	0.3965911797267606
MILLER-DIEKER SYNDROME	0.03198656	0.3959018972076184
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.03185503	0.39427393294576224
6Q16 MICRODELETION SYNDROME	0.03176756	0.39319130514993955
NIPAH VIRUS DISEASE	0.03169214	0.3922578218029526
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0316284	0.39146890336570855
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.031622	0.3913896897165344
FRAGILE X SYNDROME	0.03151734	0.3900942990098829
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.03150169	0.3899005968833867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.031432800000000004	0.3890479362128228
OBESITY DUE TO SIM1 DEFICIENCY	0.03140669	0.3887247692784575
GAUCHER DISEASE, PERINATAL LETHAL	0.031130659999999998	0.3853083093438406
FATCO SYNDROME	0.031130659999999998	0.3853083093438406
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.03105588	0.38438274736177114
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.38438274736177114
CLASSIC PHENYLKETONURIA	0.03103567	0.3841326055102383
C SYNDROME	0.03087864	0.3821890243649537
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.03078985	0.3810900587539889
HUNTINGTON DISEASE; HD	0.03076024	0.3807235718552315
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.3807235718552315
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.3807235718552315
MOSAIC TRISOMY 9	0.030753990000000002	0.38064621477595983
NEPHRONOPHTHISIS 11; NPHP11	0.030717499999999995	0.3801945732043401
XQ28 (MECP2) DUPLICATION	0.0306985	0.37995940768335434
FRYNS SYNDROME	0.030689390000000004	0.37984665200460804
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.030414699999999996	0.37644677742778687
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0303993	0.37625616958446156
CRANIOFACIOFRONTODIGITAL SYNDROME	0.030012849999999997	0.3714730266589364
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.029935989999999996	0.3705217202408853
CHROMOSOME 15Q25 DELETION SYNDROME	0.02990666	0.37015869893927933
ADAMS-OLIVER SYNDROME 5; AOS5	0.02980395	0.36888744364136056
MENTAL RETARDATION, X-LINKED 21	0.02976955	0.3684616702770494
MECKEL SYNDROME, TYPE 1; MKS1	0.02972996	0.36797165959411104
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.029670619999999995	0.3672372005406741
HARTNUP DISORDER	0.029592100000000003	0.36626534808236855
TIMOTHY SYNDROME; TS	0.02956065	0.3658760872594735
BRONCHOPULMONARY DYSPLASIA	0.029538639999999998	0.3656036665691104
2Q23.1 MICRODUPLICATION SYNDROME	0.029529620000000003	0.36549202483230564
HAIRY EARS, Y-LINKED	0.0294118	0.3640337510595397
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	0.3640337510595397
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0294118	0.3640337510595397
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0294118	0.3640337510595397
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.3640337510595397
OSSIFIED EAR CARTILAGES	0.0294118	0.3640337510595397
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.3640337510595397
EAR MALFORMATION	0.0294118	0.3640337510595397
EAR FOLDING	0.0294118	0.3640337510595397
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.3640337510595397
OSTEOMA OF MIDDLE EAR	0.0294118	0.3640337510595397
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0294118	0.3640337510595397
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.3640337510595397
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0294118	0.3640337510595397
BLAU SYNDROME	0.0294118	0.3640337510595397
EAR WITHOUT HELIX	0.0294118	0.3640337510595397
DARWINIAN POINT OF PINNA	0.0294118	0.3640337510595397
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	0.3640337510595397
OTOONYCHOPERONEAL SYNDROME	0.0294118	0.3640337510595397
AREDYLD	0.0294118	0.3640337510595397
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.3640337510595397
ALKAPTONURIA	0.0294118	0.3640337510595397
EAR WAX, WET/DRY	0.0294118	0.3640337510595397
MUSICAL PERFECT PITCH	0.0294118	0.3640337510595397
20Q11.2 MICRODUPLICATION SYNDROME	0.02932785	0.36299469077076285
DISTAL MONOSOMY 9P	0.029304010000000002	0.3626996199275891
DISTAL TRISOMY 6P	0.029304010000000002	0.3626996199275891
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.029304010000000002	0.3626996199275891
ENCEPHALITIS LETHARGICA	0.029216370000000002	0.3616148880192102
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.02918584	0.361237014158384
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.02918584	0.361237014158384
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.0290068	0.35902101232273637
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.02881156	0.35660450093761664
COFFIN-SIRIS SYNDROME 7; CSS7	0.0287872	0.3563029939854474
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.02864264	0.3545137556847257
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.3536320087523556
DYSOSTEOSCLEROSIS	0.0285714	0.3536320087523556
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.3536320087523556
ACHONDROPLASIA	0.0285714	0.3536320087523556
SCHEIE SYNDROME	0.0285714	0.3536320087523556
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.0285714	0.3536320087523556
CHERUBISM	0.0285714	0.3536320087523556
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.3536320087523556
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.02830489	0.35033337912088536
PALLISTER-KILLIAN SYNDROME	0.02829293	0.35018534861399114
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.02825394	0.3497027642106629
CAUDAL REGRESSION SEQUENCE	0.02822181	0.3493050869375431
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.02819178	0.34893340164305864
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.02819178	0.34893340164305864
16P11.2P12.2 MICRODELETION SYNDROME	0.028186239999999998	0.3488648323279922
WOLFRAM-LIKE SYNDROME	0.028130160000000005	0.34817072272710353
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.02810364	0.347842481168338
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0278532	0.344742752059091
LEIGH SYNDROME; LS	0.0278532	0.344742752059091
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.027777800000000002	0.34380951625475775
301410 NEURAL TUBE DEFECTS, X-LINKEDSPINA BIFIDA, X-LINKED, INCLUDED	0.027777800000000002	0.34380951625475775
MICROHYDRANENCEPHALY; MHAC	0.027777800000000002	0.34380951625475775
SPINA BIFIDA-HYPOSPADIAS SYNDROME	0.027777800000000002	0.34380951625475775
FRONTAL ENCEPHALOCELE	0.027777800000000002	0.34380951625475775
DUPLICATION OF THE PITUITARY GLAND	0.027777800000000002	0.34380951625475775
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.027777800000000002	0.34380951625475775
ISOLATED KLIPPEL-FEIL SYNDROME	0.027777800000000002	0.34380951625475775
ANENCEPHALY; ANPH	0.027777800000000002	0.34380951625475775
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.34380951625475775
ACROPECTOROVERTEBRAL DYSPLASIA	0.027777800000000002	0.34380951625475775
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.027777800000000002	0.34380951625475775
NAIL-PATELLA SYNDROME	0.027777800000000002	0.34380951625475775
NEUROFIBROMATOSIS, TYPE I	0.027777800000000002	0.34380951625475775
BASAL CELL NEVUS SYNDROME	0.027777800000000002	0.34380951625475775
ANOPHTHALMIA PLUS SYNDROME	0.027777800000000002	0.34380951625475775
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.02775133	0.3434818935526264
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.027751329999999998	0.34348189355262637
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.027708609999999995	0.34295314244438874
TEMPLE SYNDROME	0.027634159999999998	0.34203166491610476
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.02746664	0.3399582476489707
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.027347820000000002	0.3384875967435214
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.33755844539297364
PROGRESSIVE SUPRANUCLEAR PALSY	0.02717174	0.3363082312206168
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.3363082312206168
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.02711961	0.3356630112938278
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.02711961	0.3356630112938278
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.3356630112938278
MUSCULAR HYPERTONIA, LETHAL	0.0270008	0.3341924841597053
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0270008	0.3341924841597053
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.02697721	0.3339005075997024
FONTAINE PROGEROID SYNDROME; FPS	0.02696699	0.33377401330367734
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0269439	0.33348822531001615
C SYNDROME	0.0269215	0.3332109775379065
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.026914450000000003	0.33312371875248814
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.026894610000000003	0.3328781564400482
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.02682155	0.3319738831261942
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.026795090000000004	0.3316463841953898
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.02678569	0.33153003914816515
SCIMITAR SYNDROME	0.02678569	0.33153003914816515
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.02678569	0.33153003914816515
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.02665516	0.32991445201899244
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518481
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518481
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02648988	0.3278687595290693
SHUKLA-VERNON SYNDROME; SHUVER	0.02646159	0.32751861044545405
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.02643455	0.3271839327776932
ALZHEIMER DISEASE 10	0.0263158	0.3257141482715317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0263158	0.3257141482715317
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.3257141482715317
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0263158	0.3257141482715317
7Q11.23 DUPLICATION SYNDROME	0.0263158	0.3257141482715317
HYPERLYSINEMIA, TYPE I	0.0263158	0.3257141482715317
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.3257141482715317
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.3257141482715317
ALZHEIMER DISEASE 3; AD	0.0263158	0.3257141482715317
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.02626039	0.32502833134954096
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.02619096	0.3241689870273279
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.3240781388734313
BAND HETEROTOPIA; BH	0.02611428	0.3232199084931598
COFFIN-SIRIS SYNDROME 8; CSS8	0.026070219999999998	0.32267457202712635
AARSKOG-SCOTT SYNDROME	0.02605704	0.32251144141835825
RICHARDS-RUNDLE SYNDROME; RRNS	0.02601594	0.3220027412650679
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.025998209999999997	0.32178329470259
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.321090175272316
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.025873930000000003	0.320245064652689
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.02586609	0.3201480279324506
OCULOFACIOCARDIODENTAL SYNDROME	0.0258161	0.3195292950696042
FAMILIAL COLD URTICARIA	0.025784539999999998	0.319138672762114
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.025784539999999998	0.319138672762114
PRIMARY PARATHYROID HYPERPLASIA	0.025784539999999998	0.319138672762114
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.025784539999999998	0.319138672762114
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.025784539999999998	0.319138672762114
PANHYPOPHYSITIS	0.025784539999999998	0.319138672762114
PARATHYROID CARCINOMA	0.025784539999999998	0.319138672762114
FAMILIAL HYPERALDOSTERONISM TYPE III	0.025784539999999998	0.319138672762114
FAMILIAL HYPERALDOSTERONISM TYPE I	0.025784539999999998	0.319138672762114
AMYLOIDOSIS	0.025739349999999998	0.3185793501361482
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.02572202	0.3183648544267438
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.02568185	0.31786766500684893
LETTERER-SIWE DISEASE	0.02557931	0.3165985138214865
RETT SYNDROME	0.02557119	0.31649801150409673
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.02557119	0.31649801150409673
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.02553045	0.31599376711857236
MOSAIC TRISOMY 1	0.025384129999999998	0.31418274506432775
TRISOMY 1Q	0.025384129999999998	0.31418274506432775
AGEL AMYLOIDOSIS	0.02527774	0.3128659419181339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.025015199999999998	0.30961644950341694
SCHIZOPHRENIA 4	0.025	0.3094283170866283
SCHIZOPHRENIA 15; SCZD15	0.025	0.3094283170866283
MONILETHRIX	0.025	0.3094283170866283
ACATALASEMIA	0.025	0.3094283170866283
SCHIZOPHRENIA 19; SCZD19	0.025	0.3094283170866283
MADRAS MOTOR NEURON DISEASE	0.025	0.3094283170866283
HYPERPROLINEMIA TYPE 1	0.025	0.3094283170866283
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.30885463698674964
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.30885463698674964
CYSTINOSIS	0.024953649999999997	0.30885463698674964
TOXIC EPIDERMAL NECROLYSIS	0.024953649999999997	0.30885463698674964
SARCOSINEMIA	0.02479028	0.306832584820252
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.024684859999999996	0.30552778749276105
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.024595	0.30441557834982486
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.024595	0.30441557834982486
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.024595	0.30441557834982486
FRAGILE X MENTAL RETARDATION SYNDROME	0.02458615	0.3043060407255762
ALG13-CDG	0.02458615	0.3043060407255762
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.02444218	0.30252410493313775
RIFT VALLEY FEVER	0.02441459	0.30218261984240097
17Q12 MICRODUPLICATION SYNDROME	0.02441363	0.3021707377950248
SCHWARTZ-JAMPEL SYNDROME	0.02438755	0.3018479421746401
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.3015367810589778
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.02429672	0.30072372721300095
LEGIONELLOSIS	0.02429672	0.30072372721300095
BENIGN FAMILIAL INFANTILE EPILEPSY	0.02429672	0.30072372721300095
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.02428865	0.3006238437522453
AMISH INFANTILE EPILEPSY SYNDROME	0.024255310000000002	0.30021119014857867
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.024255310000000002	0.30021119014857867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.30021119014857867
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024255310000000002	0.30021119014857867
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.024255310000000002	0.30021119014857867
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02397014	0.2966816032212349
FIBROCHONDROGENESIS 1; FBCG1	0.02396516	0.29661996510047123
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.02396516	0.29661996510047123
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.02388548	0.29563375516825274
HYPERTELORISM, TEEBI TYPE; TBHS	0.02387297	0.2954789172383826
BARATELA-SCOTT SYNDROME	0.023845349999999998	0.29513706083366525
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0238095	0.29469334062696306
DISTAL MONOSOMY 7Q36	0.0238095	0.29469334062696306
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.29469334062696306
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0238095	0.29469334062696306
CEREBROFACIOTHORACIC DYSPLASIA	0.0238095	0.29469334062696306
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.29469334062696306
DISTAL TRISOMY 5Q	0.0238095	0.29469334062696306
H SYNDROME	0.0238095	0.29469334062696306
SIALIDOSIS TYPE 1	0.0238095	0.29469334062696306
FREEMAN-SHELDON SYNDROME	0.0238095	0.29469334062696306
SULFOCYSTEINURIA	0.0238095	0.29469334062696306
HURLER-SCHEIE SYNDROME	0.0238095	0.29469334062696306
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0238095	0.29469334062696306
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0238095	0.29469334062696306
ASPARTYLGLUCOSAMINURIA; AGU	0.0238095	0.29469334062696306
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0238095	0.29469334062696306
PSEUDOMYXOMA PERITONEI	0.0238095	0.29469334062696306
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.29469334062696306
BRITTLE CORNEA SYNDROME	0.0238095	0.29469334062696306
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0238095	0.29469334062696306
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0238095	0.29469334062696306
MUCOPOLYSACCHARIDOSIS TYPE 4	0.0238095	0.29469334062696306
GERODERMA OSTEODYSPLASTICA	0.0238095	0.29469334062696306
NON-DISTAL TRISOMY 13Q	0.0238095	0.29469334062696306
TRISOMY 8P	0.0238095	0.29469334062696306
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0238095	0.29469334062696306
MEHMO SYNDROME	0.0238095	0.29469334062696306
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0238095	0.29469334062696306
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0238095	0.29469334062696306
6P22 MICRODELETION SYNDROME	0.0238095	0.29469334062696306
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02380949	0.2946932168556362
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.02377625	0.2942818009652378
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.023692820000000003	0.29324917678545637
KAGAMI-OGATA SYNDROME	0.023650860000000003	0.29272983229805816
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.02354496	0.2914190939468792
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0235043	0.2909158397319695
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0235043	0.2909158397319695
ADAMS-OLIVER SYNDROME 3; AOS3	0.0234672	0.2904566481094129
WARSAW BREAKAGE SYNDROME; WABS	0.0234672	0.2904566481094129
RABSON-MENDENHALL SYNDROME	0.023384389999999998	0.28943169775189515
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.023375379999999998	0.2893201797864171
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.02325945	0.28788529879442304
EMANUEL SYNDROME	0.02316353	0.2866980842274251
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.02310926	0.28602637723669344
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.023057630000000003	0.28538734587624615
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.023008380000000002	0.2847777720915855
RIDDLE SYNDROME	0.02292024	0.28368685161686485
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.02288077	0.28319832618984847
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.02286379	0.2829881624768832
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.28129880763691706
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.28129880763691706
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.28129880763691706
BETHLEM MYOPATHY 1	0.0227273	0.28129880763691706
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.28129880763691706
ARTERIES, ANOMALIES OF	0.0227273	0.28129880763691706
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.28129880763691706
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.28129880763691706
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.28129880763691706
WATSON SYNDROME	0.0227273	0.28129880763691706
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	0.28129880763691706
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.28129880763691706
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.28129880763691706
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.28129880763691706
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.28129880763691706
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.28129880763691706
THUMB DEFORMITY	0.0227273	0.28129880763691706
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.28129880763691706
COWDEN SYNDROME 6; CWS6	0.0227273	0.28129880763691706
COWDEN SYNDROME 5; CWS5	0.0227273	0.28129880763691706
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.28129880763691706
COCAINE EMBRYOFETOPATHY	0.0227273	0.28129880763691706
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.28129880763691706
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.28129880763691706
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.28129880763691706
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.28129880763691706
TAY-SACHS DISEASE; TSD	0.0227273	0.28129880763691706
LARSEN SYNDROME	0.0227273	0.28129880763691706
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.28129880763691706
INFANTILE SIALIC ACID STORAGE DISEASE	0.02268906	0.28082550608310136
RUBINSTEIN-TAYBI SYNDROME	0.02259651	0.27968000245324665
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.022426210000000002	0.2775721767572526
DONNAI-BARROW SYNDROME	0.022304690000000002	0.27606810759355793
MENTAL RETARDATION, X-LINKED 104; MRX104	0.022283240000000003	0.27580261809749756
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.02227729	0.275728974158031
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.022214099999999997	0.27494686314376277
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0220982	0.27351235346574915
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.2734028158415005
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.02199145	0.27219109455178925
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.2721526016691437
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.2721526016691437
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.2721526016691437
DISTAL 16P11.2 MICRODELETION SYNDROME	0.021979810000000002	0.27204702472735376
MELNICK-NEEDLES SYNDROME	0.02191746	0.2712753105045397
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.021852120000000003	0.2704665886550021
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.02174815	0.2691797381699022
PORPHYRIA	0.02173918	0.26906871528973153
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.02157125	0.2669902233981972
INFANT BOTULISM	0.021532080000000002	0.2665054111109859
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02147715	0.26582553521268315
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.021430130000000002	0.2652435624339066
GENITOPALATOCARDIAC SYNDROME	0.021430130000000002	0.2652435624339066
KABUKI SYNDROME	0.021430130000000002	0.2652435624339066
SOTOS SYNDROME	0.021430130000000002	0.2652435624339066
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.02141731	0.2650848875929046
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02133088	0.2640151320150727
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530142
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0212766	0.2633433012530142
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0212766	0.2633433012530142
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.0212766	0.2633433012530142
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0212766	0.2633433012530142
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530142
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530142
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530142
POSTORGASMIC ILLNESS SYNDROME	0.02107764	0.260880746934312
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.02106156	0.2606817226407619
DISTAL MONOSOMY 17Q	0.02106156	0.2606817226407619
BEHÇET DISEASE	0.02106078	0.26067206847726876
PENTALOGY OF CANTRELL	0.02100738	0.2600111295919717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.02099711	0.2598840164393125
ALLAN-HERNDON-DUDLEY SYNDROME	0.02099711	0.2598840164393125
CONGENITAL HYPOTHYROIDISM	0.02089043	0.2585636239246405
ABLEPHARON MACROSTOMIA SYNDROME	0.0208857	0.2585050800870477
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.02086834	0.25829021306366273
GLAUCOMA - SLEEP APNEA	0.0208333	0.2578565183344341
APNEA, CENTRAL SLEEP	0.0208333	0.2578565183344341
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0208333	0.2578565183344341
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.2578565183344341
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0208333	0.2578565183344341
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0208333	0.2578565183344341
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.2578565183344341
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0208333	0.2578565183344341
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344341
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.2578565183344341
HYPOCHONDROPLASIA	0.0208333	0.2578565183344341
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.2578565183344341
CLEIDOCRANIAL DYSPLASIA	0.0208333	0.2578565183344341
CROUZON SYNDROME	0.0208333	0.2578565183344341
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.2578565183344341
OROFACIODIGITAL SYNDROME TYPE 14	0.0208333	0.2578565183344341
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.02079591	0.2573937373433994
KLEEFSTRA SYNDROME 2; KLEFS2	0.02079591	0.2573937373433994
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.02079591	0.2573937373433994
19P13.3 MICRODUPLICATION SYNDROME	0.02079591	0.2573937373433994
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.020676729999999997	0.25591863067018394
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.020676729999999997	0.25591863067018394
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.02057344	0.25464019663530885
FETAL ALCOHOL SYNDROME	0.02052005	0.2539793815213387
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.02051084	0.25386538812932397
HUNTER-MACDONALD SYNDROME	0.02044345	0.2530312931577852
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020408199999999998	0.25259499923069306
HELIX SYNDROME; HELIX	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.25259499923069306
OCHOA SYNDROME	0.020408199999999998	0.25259499923069306
NEPHRONOPHTHISIS 4	0.020408199999999998	0.25259499923069306
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.25259499923069306
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.25259499923069306
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.25259499923069306
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.25259499923069306
NEPHRONOPHTHISIS 1	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.25259499923069306
TERATOMA, PINEAL	0.020408199999999998	0.25259499923069306
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.25259499923069306
NEPHROGENIC DIABETES INSIPIDUS	0.020408199999999998	0.25259499923069306
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.020408199999999998	0.25259499923069306
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.02040759	0.2525874491797562
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.02039837	0.2524733320164146
CRANIOFRONTONASAL SYNDROME; CFNS	0.02039837	0.2524733320164146
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.02038343	0.2522884176541237
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.02020041	0.25002315483039583
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.02001114	0.24768053492739642
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.01986931	0.24592508619890058
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.01986931	0.24592508619890058
OHDO SYNDROME	0.01978021	0.2448222836768038
OROFACIODIGITAL SYNDROME TYPE 6	0.0197173	0.24404363825968703
MICROPHTHALMIA, LENZ TYPE	0.01957901	0.24233200458089066
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.019369610000000002	0.23974023299697306
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.01929234	0.2387838519545217
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.23803874856697713
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.23802216320918126
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.23802216320918126
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.23802216320918126
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.23802216320918126
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.23802216320918126
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.23802216320918126
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.23802216320918126
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.23802216320918126
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0192308	0.23802216320918126
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.01919035	0.23752150819213508
MEHMO SYNDROME; MEHMO	0.01902504	0.23547544438823148
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01899046	0.23504744314003725
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.23438873213862324
XQ25 MICRODUPLICATION SYNDROME	0.018883900000000002	0.23372853588128722
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.23353050175835172
PUBIC BONE DYSPLASIA	0.0188679	0.23353050175835172
RAYNAUD DISEASE	0.0188679	0.23353050175835172
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.23353050175835172
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.23353050175835172
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.23353050175835172
THROMBOCYTOPENIA 3	0.0188679	0.23353050175835172
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.23353050175835172
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.23353050175835172
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.23353050175835172
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.23353050175835172
TRACHEOBRONCHOMEGALY	0.0188679	0.23353050175835172
SPINAL ARACHNOIDITIS	0.0188679	0.23353050175835172
KNUCKLE PADS	0.0188679	0.23353050175835172
MONOPHALANGY OF GREAT TOE	0.0188679	0.23353050175835172
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.23353050175835172
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.23353050175835172
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.23353050175835172
TOE, MISSHAPEN	0.0188679	0.23353050175835172
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.23353050175835172
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.23353050175835172
VESICOURETERAL REFLUX 1	0.0188679	0.23353050175835172
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.23353050175835172
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.23353050175835172
NEPHROSIALIDOSIS	0.0188679	0.23353050175835172
HHHH SYNDROME	0.0188679	0.23353050175835172
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.23353050175835172
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.23353050175835172
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.23353050175835172
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.23353050175835172
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.23353050175835172
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.23353050175835172
VAN DEN BOSCH SYNDROME	0.0188679	0.23353050175835172
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.23353050175835172
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.23353050175835172
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.23353050175835172
CARPAL DISPLACEMENT	0.0188679	0.23353050175835172
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.23353050175835172
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.23353050175835172
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.23353050175835172
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.23353050175835172
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.23353050175835172
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.23353050175835172
CHROMOSOME 2Q37 DELETION SYNDROME	0.01882384	0.2329851652923183
CK SYNDROME	0.01869713	0.23141685880999638
9Q21.13 MICRODELETION SYNDROME	0.018616209999999998	0.23041530123325038
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.01857585	0.2299157601581458
RHEUMATIC FEVER	0.01857585	0.2299157601581458
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.01857585	0.2299157601581458
ABETAL34V AMYLOIDOSIS	0.01857585	0.2299157601581458
SNEDDON SYNDROME	0.01857585	0.2299157601581458
FAMILIAL PAROXYSMAL ATAXIA	0.01857585	0.2299157601581458
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.01857585	0.2299157601581458
PFAPA SYNDROME	0.01857585	0.2299157601581458
GORLIN-CHAUDHRY-MOSS SYNDROME	0.018559199999999998	0.229709680898966
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.01833334	0.22691418171107863
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01833334	0.22691418171107863
DUBOWITZ SYNDROME	0.01831193	0.22664918730032563
CINCA SYNDROME	0.01820728	0.22535392036500101
HARTSFIELD SYNDROME; HRTFDS	0.0181218	0.2242959230632184
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.018031190000000002	0.2231744310707697
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.01771795	0.21929741802900102
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.01771795	0.21929741802900102
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.01771795	0.21929741802900102
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.01771795	0.21929741802900102
EVEN-PLUS SYNDROME	0.017682089999999998	0.21885357405097192
OMPHALOCELE	0.01766262	0.2186125912776249
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.01766224	0.21860788796720515
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01761468	0.21801923153677957
CHROMOSOME 18Q DELETION SYNDROME	0.01761468	0.21801923153677957
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.017611790000000002	0.2179834616233244
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0175439	0.21714317808544395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0175439	0.21714317808544395
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0175439	0.21714317808544395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544395
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.0175439	0.21714317808544395
ISOLATED COMPLEX I DEFICIENCY	0.0175439	0.21714317808544395
HEART AND BRAIN MALFORMATION SYNDROME	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.0175439	0.21714317808544395
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0175439	0.21714317808544395
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.0175439	0.21714317808544395
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0175439	0.21714317808544395
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544395
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0175439	0.21714317808544395
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0175439	0.21714317808544395
WILSON-TURNER SYNDROME	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0175439	0.21714317808544395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0175439	0.21714317808544395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0175439	0.21714317808544395
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0175439	0.21714317808544395
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544395
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0175439	0.21714317808544395
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544395
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.0175439	0.21714317808544395
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0175439	0.21714317808544395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0175439	0.21714317808544395
1Q41Q42 MICRODELETION SYNDROME	0.01754386	0.2171426830001366
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.21675676400306618
ALPHA-MANNOSIDOSIS	0.01750485	0.21665985105415458
TOWNES-BROCKS SYNDROME 1; TBS1	0.0174314	0.2157507506585541
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.017424540000000002	0.21566584352834556
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.017399309999999998	0.21535356847074164
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.017399309999999998	0.21535356847074164
184705 STEINFELD SYNDROME	0.017399309999999998	0.21535356847074164
FANCONI ANEMIA	0.017399309999999998	0.21535356847074164
COFFIN-SIRIS SYNDROME 2; CSS2	0.017399309999999998	0.21535356847074164
CAMPOMELIC DYSPLASIA	0.017399309999999998	0.21535356847074164
COFFIN-SIRIS SYNDROME 3; CSS3	0.017399309999999998	0.21535356847074164
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.017399309999999998	0.21535356847074164
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.017399309999999998	0.21535356847074164
FRANK-TER HAAR SYNDROME; FTHS	0.017399309999999998	0.21535356847074164
ZTTK SYNDROME; ZTTKS	0.017399309999999998	0.21535356847074164
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.017399309999999998	0.21535356847074164
COFFIN-SIRIS SYNDROME 4; CSS4	0.017399309999999998	0.21535356847074164
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.017399309999999998	0.21535356847074164
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.017399309999999998	0.21535356847074164
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.017399309999999998	0.21535356847074164
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.017369279999999997	0.2149818831762572
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.017261890000000002	0.21365270289737995
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.2133990954486957
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.2133990954486957
269800 SENILE PLAQUE FORMATION	0.0172414	0.2133990954486957
JUMPING FRENCHMAN OF MAINE	0.0172414	0.2133990954486957
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.2133990954486957
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.2133990954486957
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.2133990954486957
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.2133990954486957
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.2133990954486957
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.2133990954486957
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.2133990954486957
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.2133990954486957
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.2133990954486957
MOTION SICKNESS	0.0172414	0.2133990954486957
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.2133990954486957
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.2133990954486957
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.2133990954486957
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.2133990954486957
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.2133990954486957
PALMOMENTAL REFLEX	0.0172414	0.2133990954486957
TRANSSEXUALITY	0.0172414	0.2133990954486957
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.2133990954486957
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.2133990954486957
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.2133990954486957
DIASTEMATOMYELIA	0.0172414	0.2133990954486957
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.2133990954486957
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.2133990954486957
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.2133990954486957
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.2133990954486957
CERVICAL RIB	0.0172414	0.2133990954486957
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.2133990954486957
MYOPATHY, CONGENITAL	0.0172414	0.2133990954486957
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.2133990954486957
SICKLE CELL ANEMIA	0.0172414	0.2133990954486957
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.2133990954486957
CARDIAC ARRHYTHMIA	0.0172414	0.2133990954486957
MOSAIC TRISOMY 15	0.0172414	0.2133990954486957
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.2133990954486957
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.2133990954486957
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.2133990954486957
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.2133990954486957
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.2133990954486957
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.2133990954486957
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.2133990954486957
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.2133990954486957
PELIZAEUS-MERZBACHER DISEASE	0.017175290000000003	0.2125808432069919
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.017102	0.21167372315262067
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.01707176	0.21129943866027268
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.01707176	0.21129943866027268
19P13.12 MICRODELETION SYNDROME	0.01706069	0.21116242380146674
DISTAL MONOSOMY 6P	0.01706069	0.21116242380146674
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.01704054	0.2109130245778949
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.017020709999999998	0.2106675860367818
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017020709999999998	0.2106675860367818
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026906
MYOCLONIC EPILEPSY OF INFANCY	0.01691523	0.2093620460813299
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.01691523	0.2093620460813299
EISENMENGER SYNDROME	0.01686509	0.20874145664858093
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.01681676	0.20814326982598907
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.016787540000000004	0.2077816100089783
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.20679341973553036
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185227
KENNERKNECHT SYNDROME	0.0166122	0.20561140356425947
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01654481	0.20477730859272072
BLADDER EXSTROPHY	0.01654481	0.20477730859272072
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01651533	0.2044124307212122
KAWASAKI DISEASE	0.01651533	0.2044124307212122
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.01651533	0.2044124307212122
CHARGE SYNDROME	0.01650895	0.2043334646146917
HYPERTELORISM, TEEBI TYPE	0.01650895	0.2043334646146917
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062438
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.0161783	0.20024096569290395
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.01613409	0.19969377265696792
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.01613409	0.19969377265696792
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.01613409	0.19969377265696792
MEIER-GORLIN SYNDROME 7	0.01613409	0.19969377265696792
%608572 BURN-MCKEOWN SYNDROME	0.01613409	0.19969377265696792
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.1996307730516091
AUTOIMMUNE HYPOPARATHYROIDISM	0.01608196	0.19904855273017888
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.01608196	0.19904855273017888
MENKES DISEASE	0.01605748	0.1987455605220877
WEAVER SYNDROME	0.01605748	0.1987455605220877
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01605748	0.1987455605220877
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01596432	0.19759250684129606
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.0157563	0.19501781570048166
YUNIS-VARON SYNDROME	0.0157563	0.19501781570048166
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.01567025	0.19395276343306947
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.01567025	0.19395276343306947
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.01567025	0.19395276343306947
2P15P16.1 MICRODELETION SYNDROME	0.01551878	0.192077999145505
SPINOCEREBELLAR ATAXIA TYPE 36	0.015268400000000001	0.18897901266421904
CHROMOSOME 9P DELETION SYNDROME	0.0152475	0.1887203305911346
TENORIO SYNDROME; TNORS	0.015235409999999998	0.18857069105699145
3P25.3 MICRODELETION SYNDROME	0.01515208	0.18753930459047835
CONGENITAL ENTEROVIRUS INFECTION	0.01511477	0.18707751377005827
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.01510433	0.18694829650484288
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.01509805	0.18687056811159072
PETERS-PLUS SYNDROME; PTRPLS	0.01506219	0.18642672413356165
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01491044	0.18454849424884584
TRISOMY X	0.014835029999999999	0.18361513467318571
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.014760170000000001	0.18268858252050155
EMANUEL SYNDROME	0.014760170000000001	0.18268858252050155
PSEUDODIASTROPHIC DYSPLASIA	0.01475377	0.18260936887132734
DISTAL TRISOMY 15Q	0.01475377	0.18260936887132734
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.01475377	0.18260936887132734
CUTANEOUS MASTOCYTOSIS	0.014746890000000002	0.18252421419846515
PLAGUE	0.014746890000000002	0.18252421419846515
MALAN OVERGROWTH SYNDROME	0.014730030000000002	0.1823155357414219
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0147059	0.18201687552976986
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0147059	0.18201687552976986
TRICUSPID ATRESIA	0.0147059	0.18201687552976986
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0147059	0.18201687552976986
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0147059	0.18201687552976986
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0147059	0.18201687552976986
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0147059	0.18201687552976986
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0147059	0.18201687552976986
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0147059	0.18201687552976986
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0147059	0.18201687552976986
HARDIKAR SYNDROME	0.0147059	0.18201687552976986
TRANSALDOLASE DEFICIENCY	0.0147059	0.18201687552976986
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0147059	0.18201687552976986
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0147059	0.18201687552976986
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0147059	0.18201687552976986
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0147059	0.18201687552976986
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.0147059	0.18201687552976986
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0147059	0.18201687552976986
CHAR SYNDROME	0.014599319999999999	0.18069772072836615
MUCOPOLYSACCHARIDOSIS TYPE 3	0.01453193	0.17986362575682746
ASPARTYLGLUCOSAMINURIA	0.01453193	0.17986362575682746
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.014523910000000001	0.17976436115270608
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0144928	0.17937930855492346
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492346
MAPLE SYRUP URINE DISEASE; MSUD	0.0144928	0.17937930855492346
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492346
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.014395189999999999	0.17817117663369042
BABESIOSIS	0.01436623	0.17781273487117727
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01434937	0.17760405641413407
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.1768522693749404
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0142857	0.1768160043761778
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0142857	0.1768160043761778
QAZI-MARKOUIZOS SYNDROME	0.0142857	0.1768160043761778
MYOPATHY, DISTAL 3	0.0142857	0.1768160043761778
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0142857	0.1768160043761778
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.0142857	0.1768160043761778
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0142857	0.1768160043761778
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0142857	0.1768160043761778
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0142857	0.1768160043761778
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0142857	0.1768160043761778
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.0142857	0.1768160043761778
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0142857	0.1768160043761778
HYPOPHOSPHATASIA, ADULT	0.0142857	0.1768160043761778
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0142857	0.1768160043761778
JOUBERT SYNDROME 2	0.0142857	0.1768160043761778
WIEACKER-WOLFF SYNDROME	0.0142857	0.1768160043761778
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.1768160043761778
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.1768160043761778
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0142857	0.1768160043761778
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.0142857	0.1768160043761778
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0142857	0.1768160043761778
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0142857	0.1768160043761778
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.1768160043761778
HAREL-YOON SYNDROME; HAYOS	0.0142857	0.1768160043761778
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.1768160043761778
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.1768160043761778
FREE SIALIC ACID STORAGE DISEASE	0.0142857	0.1768160043761778
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.1768160043761778
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.1768160043761778
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0142857	0.1768160043761778
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0142857	0.1768160043761778
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0142857	0.1768160043761778
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.0142857	0.1768160043761778
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0142857	0.1768160043761778
HENNEKAM SYNDROME	0.0142857	0.1768160043761778
HOLMES-GANG SYNDROME	0.0142857	0.1768160043761778
COCKAYNE SYNDROME	0.0142857	0.1768160043761778
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0142857	0.1768160043761778
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0142857	0.1768160043761778
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0142857	0.1768160043761778
FOUNTAIN SYNDROME	0.0142857	0.1768160043761778
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0142857	0.1768160043761778
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.1768160043761778
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.0142857	0.1768160043761778
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0142857	0.1768160043761778
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0142857	0.1768160043761778
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.0142857	0.1768160043761778
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0142857	0.1768160043761778
DEXTROCARDIA	0.0142857	0.1768160043761778
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0142857	0.1768160043761778
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.1768160043761778
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.1768160043761778
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0142857	0.1768160043761778
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.0142857	0.1768160043761778
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0142857	0.1768160043761778
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0142857	0.1768160043761778
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0142857	0.1768160043761778
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.1768160043761778
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.0142857	0.1768160043761778
COFFIN-SIRIS SYNDROME	0.014266440000000002	0.1765776208006943
CONGENITAL DIAPHRAGMATIC HERNIA	0.014266440000000002	0.1765776208006943
MONOSOMY 9P	0.014266440000000002	0.1765776208006943
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.014266440000000002	0.1765776208006943
MATTHEW-WOOD SYNDROME	0.014266440000000002	0.1765776208006943
KEIPERT SYNDROME	0.014266440000000002	0.1765776208006943
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.014266440000000002	0.1765776208006943
MONOSOMY 18P	0.014266440000000002	0.1765776208006943
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.014248360000000002	0.17635384224177728
CADASIL	0.014248360000000002	0.17635384224177728
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.014248360000000002	0.17635384224177728
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.014248360000000002	0.17635384224177728
LANDAU-KLEFFNER SYNDROME	0.014236410000000001	0.17620593550620986
8P23.1 MICRODELETION SYNDROME	0.014236410000000001	0.17620593550620986
ABETA AMYLOIDOSIS, DUTCH TYPE	0.014148270000000001	0.1751150150314892
CRYPTOCOCCOSIS	0.014148270000000001	0.1751150150314892
PINEOBLASTOMA	0.014148270000000001	0.1751150150314892
INDOLENT SYSTEMIC MASTOCYTOSIS	0.014148270000000001	0.1751150150314892
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.014148270000000001	0.1751150150314892
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.014148270000000001	0.1751150150314892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.0140845	0.17432572528026463
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.0140845	0.17432572528026463
PETTIGREW SYNDROME	0.0140845	0.17432572528026463
HARLEQUIN ICHTHYOSIS	0.0140845	0.17432572528026463
CHROMOSOME 19P13.13 DELETION SYNDROME	0.0140845	0.17432572528026463
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0140845	0.17432572528026463
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.17432572528026463
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0140845	0.17432572528026463
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.17432572528026463
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.17432572528026463
2Q24 MICRODELETION SYNDROME	0.01406435	0.17407632605669282
5Q14.3 MICRODELETION SYNDROME	0.01406435	0.17407632605669282
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.013957790000000001	0.1727574187979428
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.013957790000000001	0.1727574187979428
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.013957790000000001	0.1727574187979428
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.013957790000000001	0.1727574187979428
ROBERTS SYNDROME	0.01389787	0.17201578100754952
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.01389787	0.17201578100754952
HYDROLETHALUS	0.01389787	0.17201578100754952
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01389787	0.17201578100754952
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.013888900000000001	0.17190475812737888
PURE MITOCHONDRIAL MYOPATHY	0.013888900000000001	0.17190475812737888
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.013888900000000001	0.17190475812737888
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.013888900000000001	0.17190475812737888
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.013888900000000001	0.17190475812737888
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.013888900000000001	0.17190475812737888
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.013888900000000001	0.17190475812737888
BECKER MUSCULAR DYSTROPHY	0.013888900000000001	0.17190475812737888
EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.013888900000000001	0.17190475812737888
BARTH SYNDROME; BTHS	0.013888900000000001	0.17190475812737888
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.013888900000000001	0.17190475812737888
GLYCOGEN STORAGE DISEASE XI; GSD11	0.013888900000000001	0.17190475812737888
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.013888900000000001	0.17190475812737888
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013888900000000001	0.17190475812737888
SENGERS SYNDROME	0.013888900000000001	0.17190475812737888
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.013888900000000001	0.17190475812737888
NEMALINE MYOPATHY 6	0.013888900000000001	0.17190475812737888
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.013888900000000001	0.17190475812737888
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.013888900000000001	0.17190475812737888
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.013888900000000001	0.17190475812737888
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.013888900000000001	0.17190475812737888
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013888900000000001	0.17190475812737888
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.013888900000000001	0.17190475812737888
KAPOSIFORM LYMPHANGIOMATOSIS	0.013888900000000001	0.17190475812737888
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.013888900000000001	0.17190475812737888
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.013888900000000001	0.17190475812737888
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.013888900000000001	0.17190475812737888
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.013888900000000001	0.17190475812737888
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.013888900000000001	0.17190475812737888
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.013888900000000001	0.17190475812737888
HISTIOCYTOID CARDIOMYOPATHY	0.013888900000000001	0.17190475812737888
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.013888900000000001	0.17190475812737888
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.013888900000000001	0.17190475812737888
MUSCLE GLYCOGENOSIS, X-LINKED	0.013888900000000001	0.17190475812737888
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.013888900000000001	0.17190475812737888
GLYCOGEN STORAGE DISEASE VII	0.013888900000000001	0.17190475812737888
MYOPATHIC EHLERS-DANLOS SYNDROME	0.013888900000000001	0.17190475812737888
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.013888900000000001	0.17190475812737888
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013888900000000001	0.17190475812737888
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.013888900000000001	0.17190475812737888
HAMAMY SYNDROME; HMMS	0.01380074	0.17081359011000458
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.01353276	0.1674967660934896
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.01353276	0.1674967660934896
COFFIN-SIRIS SYNDROME 6; CSS6	0.013366780000000002	0.16544240961068807
2Q31.1 MICRODELETION SYNDROME	0.01334118	0.16512555501399134
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.01331738	0.1648309792561249
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.013307010000000001	0.16470262839019736
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.013285489999999999	0.16443627249484916
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.013285489999999999	0.16443627249484916
GENITOPATELLAR SYNDROME; GTPTS	0.013285489999999999	0.16443627249484916
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0131579	0.16285707413576586
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0131579	0.16285707413576586
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0131579	0.16285707413576586
BRACHYDACTYLY, TYPE A2; BDA2	0.0131579	0.16285707413576586
MEND SYNDROME; MEND	0.0131579	0.16285707413576586
FEINGOLD SYNDROME 1; FGLDS1	0.0131579	0.16285707413576586
SYNDACTYLY TYPE 5	0.0131579	0.16285707413576586
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.0131579	0.16285707413576586
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.0131579	0.16285707413576586
CHROMOSOME 2Q35 DUPLICATION SYNDROME	0.0131579	0.16285707413576586
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0131579	0.16285707413576586
BRACHYDACTYLY TYPE A7	0.0131579	0.16285707413576586
X SMALL RINGS	0.0131579	0.16285707413576586
SYNDACTYLY, TYPE IV; SDTY4	0.0131579	0.16285707413576586
JACKSON-WEISS SYNDROME	0.0131579	0.16285707413576586
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.0131579	0.16285707413576586
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.0131579	0.16285707413576586
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0131579	0.16285707413576586
SYNDACTYLY TYPE 2	0.0131579	0.16285707413576586
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.0131579	0.16285707413576586
COOPER-JABS SYNDROME	0.01304543	0.16146501802285654
15Q14 MICRODELETION SYNDROME	0.01303049	0.16128010366056555
CORNEODERMATOOSSEOUS SYNDROME	0.012948810000000002	0.16026913946298016
CORNEODERMATOOSSEOUS SYNDROME	0.012948810000000002	0.16026913946298016
APERT SYNDROME	0.01284745	0.1590145932941841
BARTSOCAS-PAPAS SYNDROME	0.01284745	0.1590145932941841
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.01281742	0.15864290799969963
X-LINKED EHLERS-DANLOS SYNDROME	0.01278006	0.15818049832264539
ACHONDROGENESIS	0.01278006	0.15818049832264539
ACROOSTEOLYSIS DOMINANT TYPE	0.01266189	0.15671789255344032
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.012658200000000001	0.15667222093383834
AUTOSOMAL RECESSIVE AMELIA	0.012658200000000001	0.15667222093383834
PHACE SYNDROME	0.012658200000000001	0.15667222093383834
GERMAN SYNDROME	0.012658200000000001	0.15667222093383834
JOHANSON-BLIZZARD SYNDROME	0.012658200000000001	0.15667222093383834
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.012658200000000001	0.15667222093383834
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.012658200000000001	0.15667222093383834
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.012658200000000001	0.15667222093383834
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.012658200000000001	0.15667222093383834
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.012658200000000001	0.15667222093383834
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.012658200000000001	0.15667222093383834
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.012658200000000001	0.15667222093383834
CONGENITAL LARYNGEAL WEB	0.012658200000000001	0.15667222093383834
1Q44 MICRODELETION SYNDROME	0.012658200000000001	0.15667222093383834
PENTASOMY X	0.012658200000000001	0.15667222093383834
BALLER-GEROLD SYNDROME	0.012658200000000001	0.15667222093383834
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.012658200000000001	0.15667222093383834
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.012658200000000001	0.15667222093383834
NOONAN SYNDROME 2; NS2	0.012658200000000001	0.15667222093383834
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.012658200000000001	0.15667222093383834
ATRIAL SEPTAL DEFECT-ATRIOVENTRICULAR CONDUCTION DEFECTS SYNDROME	0.012658200000000001	0.15667222093383834
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.012658200000000001	0.15667222093383834
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.012658200000000001	0.15667222093383834
CHOPS SYNDROME; CHOPS	0.012658200000000001	0.15667222093383834
DISTAL MONOSOMY 13Q	0.012658200000000001	0.15667222093383834
NOONAN SYNDROME 9; NS9	0.012658200000000001	0.15667222093383834
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.012658200000000001	0.15667222093383834
NOONAN SYNDROME 10; NS10	0.012658200000000001	0.15667222093383834
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.012658200000000001	0.15667222093383834
DIPROSOPUS	0.012658200000000001	0.15667222093383834
CONGENITAL PERICARDIUM ANOMALY	0.012658200000000001	0.15667222093383834
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.012658200000000001	0.15667222093383834
TRACHEAL AGENESIS	0.012658200000000001	0.15667222093383834
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.01262272	0.156233080266229
PREECLAMPSIA	0.01262272	0.156233080266229
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.15479745664627387
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.01250673	0.15479745664627387
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.15479745664627387
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.01250673	0.15479745664627387
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01250673	0.15479745664627387
TUBEROUS SCLEROSIS-1	0.01250673	0.15479745664627387
10Q22.3Q23.3 MICRODELETION SYNDROME	0.01250673	0.15479745664627387
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.15479745664627387
OMPHALOCELE, AUTOSOMAL	0.01227131	0.15188363206993252
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.01223545	0.15143978809190342
3MC SYNDROME 1	0.01223545	0.15143978809190342
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01223545	0.15143978809190342
CODAS SYNDROME	0.01223545	0.15143978809190342
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.01223545	0.15143978809190342
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.01220592	0.15107429136376072
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.01217589	0.15070260606927624
STURGE-WEBER SYNDROME	0.01217589	0.15070260606927624
XQ25 DUPLICATION SYNDROME	0.012172490000000001	0.15066052381815248
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.012087750000000001	0.14961168559455568
RHABDOID TUMOR	0.012087750000000001	0.14961168559455568
NARP SYNDROME	0.012087750000000001	0.14961168559455568
WYBURN-MASON SYNDROME	0.012087750000000001	0.14961168559455568
MEDULLOBLASTOMA	0.012087750000000001	0.14961168559455568
AICARDI-GOUTIÈRES SYNDROME	0.012087750000000001	0.14961168559455568
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.012086	0.14959002561235957
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.012086	0.14959002561235957
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.012048200000000002	0.14912216999692463
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692463
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692463
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.012048200000000002	0.14912216999692463
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692463
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012048200000000002	0.14912216999692463
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692463
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692463
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692463
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692463
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012048200000000002	0.14912216999692463
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012048200000000002	0.14912216999692463
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.012048200000000002	0.14912216999692463
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692463
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.01198572	0.1483488467468617
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01198572	0.1483488467468617
TRANSIENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.14734728917011566
DISTAL TRISOMY 17Q	0.011904799999999998	0.14734728917011566
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.011904799999999998	0.14734728917011566
CONGENITAL HYDROCEPHALUS	0.011904799999999998	0.14734728917011566
7P22.1 MICRODUPLICATION SYNDROME	0.011904799999999998	0.14734728917011566
AA AMYLOIDOSIS	0.011904799999999998	0.14734728917011566
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.011904799999999998	0.14734728917011566
PERMANENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.14734728917011566
UNILATERAL POLYMICROGYRIA	0.011904799999999998	0.14734728917011566
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.011904799999999998	0.14734728917011566
NF1-MICRODELETION SYNDROME	0.011904799999999998	0.14734728917011566
WOLCOTT-RALLISON SYNDROME	0.011904799999999998	0.14734728917011566
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011904799999999998	0.14734728917011566
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011904799999999998	0.14734728917011566
9Q SUBTELOMERIC DELETION SYNDROME	0.011904799999999998	0.14734728917011566
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.011904799999999998	0.14734728917011566
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.011904799999999998	0.14734728917011566
CAT-EYE SYNDROME (TYPE I)	0.011904799999999998	0.14734728917011566
AFRICAN IRON OVERLOAD	0.011904799999999998	0.14734728917011566
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.011904799999999998	0.14734728917011566
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011904799999999998	0.14734728917011566
MILLER-DIEKER SYNDROME (MDS)	0.011904799999999998	0.14734728917011566
LOWRY-MACLEAN SYNDROME	0.011904799999999998	0.14734728917011566
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.011904799999999998	0.14734728917011566
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.011904799999999998	0.14734728917011566
CRANIOFACIOFRONTODIGITAL SYNDROME	0.011904799999999998	0.14734728917011566
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.011904799999999998	0.14734728917011566
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.011904799999999998	0.14734728917011566
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.01189839	0.14726795174961468
ERMINE PHENOTYPE	0.01189839	0.14726795174961468
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.011831	0.14643385677807597
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01179738	0.14601773757725786
2Q33.1 DELETION SYNDROME	0.011783980000000001	0.14585188399929944
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.011783980000000001	0.14585188399929944
AYMÉ-GRIPP SYNDROME	0.011783980000000001	0.14585188399929944
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.011783980000000001	0.14585188399929944
LOWRY-MACLEAN SYNDROME	0.011783980000000001	0.14585188399929944
ANGELMAN SYNDROME	0.011783980000000001	0.14585188399929944
ACROCALLOSAL SYNDROME	0.011783980000000001	0.14585188399929944
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01178159	0.14582230265218596
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.14582230265218596
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.01174812	0.1454080400212704
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.01174812	0.1454080400212704
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.01174812	0.1454080400212704
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01174812	0.1454080400212704
SECKEL SYNDROME 9; SCKL9	0.01174812	0.1454080400212704
8P23.1 DELETION SYNDROME	0.01174812	0.1454080400212704
WOLF-HIRSCHHORN SYNDROME	0.01174812	0.1454080400212704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.01163752	0.14403912914647915
OCULODENTODIGITAL DYSPLASIA	0.011626439999999998	0.14390199051634633
CARPENTER SYNDROME	0.011626439999999998	0.14390199051634633
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.011626439999999998	0.14390199051634633
PRIMARY CONGENITAL HYPOTHYROIDISM	0.01151988	0.1425830832575963
PERIPHERAL HYPOTHYROIDISM	0.01151988	0.1425830832575963
PERMANENT CONGENITAL HYPOTHYROIDISM	0.01151988	0.1425830832575963
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01151988	0.1425830832575963
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.01151988	0.1425830832575963
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.01151988	0.1425830832575963
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.01151988	0.1425830832575963
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.01151988	0.1425830832575963
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.01151988	0.1425830832575963
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.011450749999999999	0.14172745207518836
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.011450749999999999	0.14172745207518836
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.14172745207518836
FRIED SYNDROME	0.011450749999999999	0.14172745207518836
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01141541	0.1412900442061547
DIAMOND-BLACKFAN ANEMIA 1	0.01137955	0.14084620022812563
KNIEST-LIKE DYSPLASIA, LETHAL	0.01137955	0.14084620022812563
EBSTEIN MALFORMATION	0.01137955	0.14084620022812563
CARDIOFACIOCUTANEOUS SYNDROME	0.01137955	0.14084620022812563
RESTRICTIVE DERMOPATHY, LETHAL	0.01137955	0.14084620022812563
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01137955	0.14084620022812563
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.01137955	0.14084620022812563
INDOMETHACIN EMBRYOFETOPATHY	0.01137955	0.14084620022812563
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683447
15Q OVERGROWTH SYNDROME	0.010870850000000001	0.13454995283204693
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01082455	0.1339768915888025
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.01082455	0.1339768915888025
BOHRING-OPITZ SYNDROME	0.01078869	0.13353304761077342
RITSCHER-SCHINZEL SYNDROME 1	0.01078869	0.13353304761077342
DUANE-RADIAL RAY SYNDROME; DRRS	0.01078869	0.13353304761077342
YUNIS-VARON SYNDROME	0.01078869	0.13353304761077342
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.01078869	0.13353304761077342
ROBERTS SYNDROME; RBS	0.01078869	0.13353304761077342
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.01078869	0.13353304761077342
FACIOCARDIORENAL SYNDROME	0.01036499	0.12828885649278926
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01036499	0.12828885649278926
ADAMS-OLIVER SYNDROME 1; AOS1	0.010329129999999999	0.12784501251476016
ABRUZZO-ERICKSON SYNDROME	0.010329129999999999	0.12784501251476016
ACROCARDIOFACIAL SYNDROME	0.010329129999999999	0.12784501251476016
TOWNES-BROCKS SYNDROME	0.010329129999999999	0.12784501251476016
CORNELIA DE LANGE SYNDROME 3	0.010329129999999999	0.12784501251476016
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.010329129999999999	0.12784501251476016
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.010309299999999999	0.12759957397364707
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010309299999999999	0.12759957397364707
GLYCEROL KINASE DEFICIENCY; GKD	0.010309299999999999	0.12759957397364707
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010309299999999999	0.12759957397364707
GABA-TRANSAMINASE DEFICIENCY	0.010309299999999999	0.12759957397364707
MEVALONIC ACIDURIA; MEVA	0.010309299999999999	0.12759957397364707
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.12759957397364707
HYDROCEPHALUS, NORMAL-PRESSURE	0.010309299999999999	0.12759957397364707
PROPIONIC ACIDEMIA	0.010309299999999999	0.12759957397364707
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.12759957397364707
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.010309299999999999	0.12759957397364707
CREE MENTAL RETARDATION SYNDROME	0.010309299999999999	0.12759957397364707
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010309299999999999	0.12759957397364707
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.010309299999999999	0.12759957397364707
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.010309299999999999	0.12759957397364707
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010309299999999999	0.12759957397364707
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010309299999999999	0.12759957397364707
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.010309299999999999	0.12759957397364707
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010309299999999999	0.12759957397364707
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010309299999999999	0.12759957397364707
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010309299999999999	0.12759957397364707
GAUCHER DISEASE, TYPE II	0.010309299999999999	0.12759957397364707
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010309299999999999	0.12759957397364707
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010309299999999999	0.12759957397364707
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.010309299999999999	0.12759957397364707
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.010309299999999999	0.12759957397364707
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010309299999999999	0.12759957397364707
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.010309299999999999	0.12759957397364707
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010309299999999999	0.12759957397364707
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.010309299999999999	0.12759957397364707
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.010309299999999999	0.12759957397364707
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010309299999999999	0.12759957397364707
PIERSON SYNDROME	0.010309299999999999	0.12759957397364707
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.010309299999999999	0.12759957397364707
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010309299999999999	0.12759957397364707
VICI SYNDROME; VICIS	0.010309299999999999	0.12759957397364707
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.010309299999999999	0.12759957397364707
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.010309299999999999	0.12759957397364707
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010309299999999999	0.12759957397364707
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.010309299999999999	0.12759957397364707
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.010309299999999999	0.12759957397364707
LISSENCEPHALY 5; LIS5	0.010309299999999999	0.12759957397364707
ADAMS-OLIVER SYNDROME 2; AOS2	0.010309299999999999	0.12759957397364707
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010309299999999999	0.12759957397364707
MARINESCO-SJOGREN SYNDROME; MSS	0.010309299999999999	0.12759957397364707
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010309299999999999	0.12759957397364707
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010309299999999999	0.12759957397364707
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.010309299999999999	0.12759957397364707
SEPTOOPTIC DYSPLASIA	0.010309299999999999	0.12759957397364707
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010309299999999999	0.12759957397364707
PYRUVATE CARBOXYLASE DEFICIENCY	0.010309299999999999	0.12759957397364707
REVESZ SYNDROME	0.010309299999999999	0.12759957397364707
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010309299999999999	0.12759957397364707
ARIMA SYNDROME	0.010309299999999999	0.12759957397364707
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.010309299999999999	0.12759957397364707
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.010309299999999999	0.12759957397364707
NIEMANN-PICK DISEASE, TYPE A	0.010309299999999999	0.12759957397364707
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010309299999999999	0.12759957397364707
CHROMOSOME 4Q21 DELETION SYNDROME	0.010309299999999999	0.12759957397364707
MENTAL RETARDATION, X-LINKED 91; MRX91	0.010309299999999999	0.12759957397364707
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010309299999999999	0.12759957397364707
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010309299999999999	0.12759957397364707
ACQUIRED METHEMOGLOBINEMIA	0.010302450000000001	0.12751479061476537
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.01026174	0.12701091754322147
FLOATING-HARBOR SYNDROME	0.01026174	0.12701091754322147
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.010203819999999999	0.12629403401819517
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.010203819999999999	0.12629403401819517
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.01001844	0.12399956116133443
SCRUB TYPHUS	0.00992179	0.1228033112874775
ALPORT SYNDROME	0.00992179	0.1228033112874775
YELLOW FEVER	0.00992179	0.1228033112874775
IDIOPATHIC PANUVEITIS	0.00992179	0.1228033112874775
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984131
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.009820780000000001	0.1215530971151207
GIANT CELL ARTERITIS	0.009820780000000001	0.1215530971151207
L1 SYNDROME	0.009820780000000001	0.1215530971151207
CENTRAL NEUROCYTOMA	0.009820780000000001	0.1215530971151207
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.12134441865807749
PHACE ASSOCIATION	0.00980392	0.12134441865807749
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.12134441865807749
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.12134441865807749
VON HIPPEL-LINDAU DISEASE	0.00980392	0.12134441865807749
PULMONARY ARTERIOVENOUS MALFORMATION	0.00980392	0.12134441865807749
CLASSIC HODGKIN LYMPHOMA	0.00980392	0.12134441865807749
MALIGNANT ATROPHIC PAPULOSIS	0.00980392	0.12134441865807749
SUBEPENDYMOMA	0.00980392	0.12134441865807749
CITRULLINEMIA TYPE I	0.00980392	0.12134441865807749
STORMORKEN SYNDROME; STRMK	0.00980392	0.12134441865807749
EPENDYMOMA	0.00980392	0.12134441865807749
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.12134441865807749
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.12134441865807749
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.12134441865807749
IMMUNOGLOBULIN A VASCULITIS	0.00980392	0.12134441865807749
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.12134441865807749
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.12134441865807749
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.00980392	0.12134441865807749
ARACHNOIDITIS	0.00980392	0.12134441865807749
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.00980392	0.12134441865807749
VIRAL HEMORRHAGIC FEVER	0.00980392	0.12134441865807749
EPISODIC ATAXIA, TYPE 2	0.00980392	0.12134441865807749
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.12134441865807749
SYSTEMIC SCLEROSIS	0.00980392	0.12134441865807749
WALDENSTRÖM MACROGLOBULINEMIA	0.00980392	0.12134441865807749
KERION CELSI	0.00980392	0.12134441865807749
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.00980392	0.12134441865807749
TAKAYASU ARTERITIS	0.00980392	0.12134441865807749
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00980392	0.12134441865807749
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00980392	0.12134441865807749
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00980392	0.12134441865807749
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00980392	0.12134441865807749
BERNARD-SOULIER SYNDROME	0.00980392	0.12134441865807749
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00980392	0.12134441865807749
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.12134441865807749
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00980392	0.12134441865807749
EPISODIC ATAXIA TYPE 7	0.00980392	0.12134441865807749
BLACKFAN-DIAMOND ANEMIA	0.00980392	0.12134441865807749
FAMILIAL VISCERAL MYOPATHY	0.00976801	0.12089995582341424
DOWN SYNDROME	0.00976801	0.12089995582341424
MESOMELIA-SYNOSTOSES SYNDROME	0.00976801	0.12089995582341424
INCONTINENTIA PIGMENTI	0.00973798	0.1205282705289298
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009687600000000001	0.11990471058433681
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.009687600000000001	0.11990471058433681
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.009687600000000001	0.11990471058433681
20Q13.33 MICRODELETION SYNDROME	0.009687600000000001	0.11990471058433681
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.009687600000000001	0.11990471058433681
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009687600000000001	0.11990471058433681
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.009665449999999999	0.11963055709539805
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00937055	0.11598054066704419
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704419
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704419
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704419
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00937055	0.11598054066704419
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704419
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00937055	0.11598054066704419
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704419
BETA-THALASSEMIA MAJOR	0.00937055	0.11598054066704419
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704419
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00937055	0.11598054066704419
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704419
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704419
FABRY DISEASE	0.00937055	0.11598054066704419
BECKWITH-WIEDEMANN SYNDROME	0.00925926	0.11460308957070135
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00925926	0.11460308957070135
ISOLATED TRIGONOCEPHALY	0.00925926	0.11460308957070135
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00925926	0.11460308957070135
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.00925926	0.11460308957070135
ACROCEPHALOSYNDACTYLY	0.00925926	0.11460308957070135
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00925926	0.11460308957070135
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00925926	0.11460308957070135
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00925926	0.11460308957070135
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00925926	0.11460308957070135
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00925926	0.11460308957070135
HOLOPROSENCEPHALY 7	0.00925926	0.11460308957070135
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00925926	0.11460308957070135
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00925926	0.11460308957070135
SHPRINTZEN OMPHALOCELE SYNDROME	0.00925926	0.11460308957070135
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00925926	0.11460308957070135
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.00925926	0.11460308957070135
MANITOBA OCULOTRICHOANAL SYNDROME	0.00925926	0.11460308957070135
MELNICK-NEEDLES SYNDROME	0.00925926	0.11460308957070135
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00925926	0.11460308957070135
FETAL VALPROATE SYNDROME	0.00925926	0.11460308957070135
HYDROLETHALUS SYNDROME 1	0.00925926	0.11460308957070135
BOOMERANG DYSPLASIA	0.00925926	0.11460308957070135
OMPHALOCELE	0.00925926	0.11460308957070135
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.00925926	0.11460308957070135
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00925926	0.11460308957070135
FIBROCHONDROGENESIS	0.00925926	0.11460308957070135
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00925926	0.11460308957070135
COLONIC ATRESIA	0.00925926	0.11460308957070135
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575339
SPINOCEREBELLAR ATAXIA TYPE 27	0.009183779999999999	0.11366886359575339
GAPO SYNDROME; GAPOS	0.008818949999999999	0.10915331427884481
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.008818949999999999	0.10915331427884481
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.1085713415000683
LESCH-NYHAN SYNDROME	0.00877193	0.1085713415000683
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.1085713415000683
CRANIOFRONTONASAL DYSPLASIA	0.00877193	0.1085713415000683
DIAMOND-BLACKFAN ANEMIA 10	0.00877193	0.1085713415000683
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.1085713415000683
HISTIDINEMIA	0.00877193	0.1085713415000683
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.1085713415000683
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00877193	0.1085713415000683
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00877193	0.1085713415000683
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.1085713415000683
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.1085713415000683
SCLERODERMA	0.00877193	0.1085713415000683
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.1085713415000683
HERNIA, ANTERIOR DIAPHRAGMATIC	0.00877193	0.1085713415000683
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.1085713415000683
ACRO-RENAL-MANDIBULAR SYNDROME	0.00877193	0.1085713415000683
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.1085713415000683
SERKAL SYNDROME	0.00877193	0.1085713415000683
HEREDITARY FOLATE MALABSORPTION	0.00877193	0.1085713415000683
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00877193	0.1085713415000683
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.1085713415000683
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.1085713415000683
MILROY DISEASE	0.00877193	0.1085713415000683
MENTAL RETARDATION, X-LINKED 90	0.00877193	0.1085713415000683
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.1085713415000683
MICROPHTHALMIA, SYNDROMIC 12	0.00877193	0.1085713415000683
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.1085713415000683
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00877193	0.1085713415000683
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.1085713415000683
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.1085713415000683
THAKKER-DONNAI SYNDROME	0.00877193	0.1085713415000683
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.1085713415000683
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.1085713415000683
FAMILIAL DYSAUTONOMIA	0.00877193	0.1085713415000683
CUTIS LAXA-MARFANOID SYNDROME	0.00877193	0.1085713415000683
INFANTILE REFSUM DISEASE	0.00877193	0.1085713415000683
NANCE-HORAN SYNDROME	0.00877193	0.1085713415000683
DIENCEPHALIC SYNDROME	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.1085713415000683
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.1085713415000683
HISTIDINEMIA	0.00877193	0.1085713415000683
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.1085713415000683
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	0.1085713415000683
OCULOCEREBROCUTANEOUS SYNDROME	0.00877193	0.1085713415000683
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.1085713415000683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.1085713415000683
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00877193	0.1085713415000683
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.1085713415000683
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.1085713415000683
NEUROFERRITINOPATHY	0.00877193	0.1085713415000683
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.1085713415000683
DIAPHRAGMATIC HERNIA, CONGENITAL	0.00877193	0.1085713415000683
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00877193	0.1085713415000683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.1085713415000683
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.1085713415000683
DIAPHRAGMATIC HERNIA 2	0.00877193	0.1085713415000683
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.00877193	0.1085713415000683
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.1085713415000683
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00877193	0.1085713415000683
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.1085713415000683
EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA	0.00877193	0.1085713415000683
HUNTINGTON DISEASE	0.00877193	0.1085713415000683
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.1085713415000683
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.00877193	0.1085713415000683
LOCKED-IN SYNDROME	0.00877193	0.1085713415000683
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.1085713415000683
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00877193	0.1085713415000683
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.1085713415000683
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.1085713415000683
BREATH-HOLDING SPELLS	0.00877193	0.1085713415000683
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00877193	0.1085713415000683
CORTICOBASAL SYNDROME	0.00877193	0.1085713415000683
ARGININEMIA	0.00877193	0.1085713415000683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00877193	0.1085713415000683
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.1085713415000683
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.1085713415000683
CAFFEY DISEASE	0.00877193	0.1085713415000683
20Q11.2 MICRODELETION SYNDROME	0.00877193	0.1085713415000683
MONOSOMY 5P	0.00850656	0.10528682179985714
FEMORAL-FACIAL SYNDROME	0.00850656	0.10528682179985714
WEAVER SYNDROME	0.00850656	0.10528682179985714
BOHRING-OPITZ SYNDROME	0.00850656	0.10528682179985714
8Q12 MICRODUPLICATION SYNDROME	0.00844067	0.10447129252734363
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00844067	0.10447129252734363
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00840336	0.10400950170692355
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.10400950170692355
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.10400950170692355
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.10400950170692355
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.10400950170692355
GMS SYNDROME	0.00840336	0.10400950170692355
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.10400950170692355
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.10400950170692355
PEMPHIGOID GESTATIONIS	0.00840336	0.10400950170692355
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.10400950170692355
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00840336	0.10400950170692355
ROIFMAN SYNDROME; RFMN	0.00840336	0.10400950170692355
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.10400950170692355
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00840336	0.10400950170692355
ZELLWEGER SYNDROME	0.00840336	0.10400950170692355
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.10400950170692355
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.10400950170692355
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00840336	0.10400950170692355
HEC SYNDROME	0.00840336	0.10400950170692355
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.10400950170692355
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.10400950170692355
CONGENITAL TOXOPLASMOSIS	0.00840336	0.10400950170692355
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00840336	0.10400950170692355
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.10400950170692355
NEMALINE MYOPATHY 10	0.00840336	0.10400950170692355
CONGENITAL ANALBUMINEMIA	0.00840336	0.10400950170692355
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.10400950170692355
ADAMS-OLIVER SYNDROME	0.00840336	0.10400950170692355
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.10400950170692355
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.10400950170692355
RENAL TUBULAR DYSGENESIS	0.00840336	0.10400950170692355
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.10400950170692355
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.10400950170692355
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.10400950170692355
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.10400950170692355
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00840336	0.10400950170692355
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.10400950170692355
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.10400950170692355
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.10400950170692355
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.10400950170692355
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00840336	0.10400950170692355
RETINOPATHY OF PREMATURITY	0.00840336	0.10400950170692355
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.10400950170692355
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.10400950170692355
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.10400950170692355
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.10400950170692355
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.10400950170692355
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.10400950170692355
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.10400950170692355
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.10400950170692355
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.10400950170692355
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.10400950170692355
TEMPLE SYNDROME	0.00840336	0.10400950170692355
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.10400950170692355
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00840336	0.10400950170692355
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.10400950170692355
MICROFORM HOLOPROSENCEPHALY	0.00840336	0.10400950170692355
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.10400950170692355
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.10400950170692355
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00835253	0.10338037205262303
RENPENNING SYNDROME 1; RENS1	0.007902300000000001	0.09780781560454653
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.0078125	0.09669634908957134
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0078125	0.09669634908957134
BARDET-BIEDL SYNDROME 6; BBS6	0.0078125	0.09669634908957134
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.0078125	0.09669634908957134
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0078125	0.09669634908957134
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0078125	0.09669634908957134
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0078125	0.09669634908957134
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.0078125	0.09669634908957134
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.0078125	0.09669634908957134
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0078125	0.09669634908957134
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0078125	0.09669634908957134
WAHAB SYNDROME	0.0078125	0.09669634908957134
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.0078125	0.09669634908957134
BARTSOCAS-PAPAS SYNDROME; BPS	0.0078125	0.09669634908957134
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.0078125	0.09669634908957134
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.0078125	0.09669634908957134
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.0078125	0.09669634908957134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0078125	0.09669634908957134
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0078125	0.09669634908957134
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.0078125	0.09669634908957134
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0078125	0.09669634908957134
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0078125	0.09669634908957134
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.0078125	0.09669634908957134
TUKEL SYNDROME	0.0078125	0.09669634908957134
CURRY-JONES SYNDROME	0.0078125	0.09669634908957134
BLOOM SYNDROME	0.0078125	0.09669634908957134
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.0078125	0.09669634908957134
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0078125	0.09669634908957134
JOUBERT SYNDROME 17; JBTS17	0.0078125	0.09669634908957134
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0078125	0.09669634908957134
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.0078125	0.09669634908957134
TEEBI-SHALTOUT SYNDROME; TBSH	0.0078125	0.09669634908957134
GRANGE SYNDROME	0.0078125	0.09669634908957134
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0078125	0.09669634908957134
CRANIOECTODERMAL DYSPLASIA 3	0.0078125	0.09669634908957134
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0078125	0.09669634908957134
SUMMITT SYNDROME	0.0078125	0.09669634908957134
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0078125	0.09669634908957134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.0078125	0.09669634908957134
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.0078125	0.09669634908957134
BARDET-BIEDL SYNDROME 1; BBS1	0.0078125	0.09669634908957134
GRANGE SYNDROME; GRNG	0.0078125	0.09669634908957134
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0078125	0.09669634908957134
KBG SYNDROME	0.0078125	0.09669634908957134
MOEBIUS SYNDROME; MBS	0.0078125	0.09669634908957134
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0078125	0.09669634908957134
BRACHYDACTYLY, TYPE B1	0.0078125	0.09669634908957134
ADAMS-OLIVER SYNDROME 6; AOS6	0.0078125	0.09669634908957134
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0078125	0.09669634908957134
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0078125	0.09669634908957134
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.0078125	0.09669634908957134
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0078125	0.09669634908957134
BARDET-BIEDL SYNDROME 5; BBS5	0.0078125	0.09669634908957134
BARDET-BIEDL SYNDROME 4; BBS4	0.0078125	0.09669634908957134
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0078125	0.09669634908957134
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.0078125	0.09669634908957134
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0078125	0.09669634908957134
CAMPTOBRACHYDACTYLY	0.0078125	0.09669634908957134
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.0078125	0.09669634908957134
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0078125	0.09669634908957134
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.0078125	0.09669634908957134
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0078125	0.09669634908957134
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0078125	0.09669634908957134
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00771553	0.09549613853325573
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.0075575	0.09354018025528774
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.0075575	0.09354018025528774
CHÉDIAK-HIGASHI SYNDROME	0.0075216400000000004	0.09309633627725868
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00735294	0.0910083139935581
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00735294	0.0910083139935581
SYNDACTYLY TYPE 1	0.00735294	0.0910083139935581
PALLISTER-HALL SYNDROME	0.00735294	0.0910083139935581
SYNPOLYDACTYLY 2	0.00735294	0.0910083139935581
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00735294	0.0910083139935581
SYNDACTYLY TYPE 4	0.00735294	0.0910083139935581
CURRY-JONES SYNDROME	0.00735294	0.0910083139935581
OROFACIODIGITAL SYNDROME VI	0.00735294	0.0910083139935581
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00735294	0.0910083139935581
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.00735294	0.0910083139935581
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00735294	0.0910083139935581
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00735294	0.0910083139935581
SPLIT-HAND/FOOT MALFORMATION 6	0.00735294	0.0910083139935581
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00735294	0.0910083139935581
CRANE-HEISE SYNDROME	0.00735294	0.0910083139935581
19Q13.11 MICRODELETION SYNDROME	0.00735294	0.0910083139935581
LINEAR VERRUCOUS NEVUS SYNDROME	0.00735294	0.0910083139935581
ADULT SYNDROME	0.00735294	0.0910083139935581
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.00735294	0.0910083139935581
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00735294	0.0910083139935581
3Q29 MICRODUPLICATION SYNDROME	0.00735294	0.0910083139935581
ZLOTOGORA-OGUR SYNDROME	0.00735294	0.0910083139935581
CENANI-LENZ SYNDROME	0.00735294	0.0910083139935581
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.00735294	0.0910083139935581
ACRO-RENAL-OCULAR SYNDROME	0.00735294	0.0910083139935581
DYSOSTOSIS WITH BRACHYDACTYLY	0.00735294	0.0910083139935581
OROFACIODIGITAL SYNDROME IX; OFD9	0.00735294	0.0910083139935581
14Q22Q23 MICRODELETION SYNDROME	0.00735294	0.0910083139935581
FEINGOLD SYNDROME	0.00735294	0.0910083139935581
NEVUS COMEDONICUS SYNDROME	0.00735294	0.0910083139935581
LIMB-MAMMARY SYNDROME	0.00735294	0.0910083139935581
JEUNE SYNDROME	0.00735294	0.0910083139935581
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00735294	0.0910083139935581
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00735294	0.0910083139935581
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00735294	0.0910083139935581
PFEIFFER SYNDROME TYPE 3	0.00735294	0.0910083139935581
LAURIN-SANDROW SYNDROME	0.00735294	0.0910083139935581
OROFACIODIGITAL SYNDROME IV; OFD4	0.00735294	0.0910083139935581
CAMPTOBRACHYDACTYLY	0.00735294	0.0910083139935581
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00735294	0.0910083139935581
PFEIFFER SYNDROME TYPE 2	0.00735294	0.0910083139935581
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00735294	0.0910083139935581
PFEIFFER SYNDROME TYPE 1	0.00735294	0.0910083139935581
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00735294	0.0910083139935581
14Q11.2 MICRODELETION SYNDROME	0.00735294	0.0910083139935581
JUBERG-HAYWARD SYNDROME	0.00735294	0.0910083139935581
8P23.1 DUPLICATION SYNDROME	0.00735294	0.0910083139935581
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00735294	0.0910083139935581
URBAN-ROGERS-MEYER SYNDROME	0.00735294	0.0910083139935581
HYPEREKPLEXIA 1; HKPX1	0.00728555	0.09017421902201939
FRANK-TER HAAR SYNDROME	0.00728555	0.09017421902201939
LEPRECHAUNISM	0.00728555	0.09017421902201939
SHPRINTZEN-GOLDBERG SYNDROME	0.00728555	0.09017421902201939
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00728555	0.09017421902201939
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00728555	0.09017421902201939
WRINKLY SKIN SYNDROME	0.00728555	0.09017421902201939
BRITTLE CORNEA SYNDROME 2; BCS2	0.00728555	0.09017421902201939
SCARF SYNDROME	0.00728555	0.09017421902201939
AUTOSOMAL DOMINANT CUTIS LAXA	0.00728555	0.09017421902201939
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00728555	0.09017421902201939
CATEL-MANZKE SYNDROME; CATMANS	0.00728555	0.09017421902201939
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00728555	0.09017421902201939
SIALIDOSIS TYPE 2	0.00728555	0.09017421902201939
HURLER SYNDROME	0.00728555	0.09017421902201939
OSTEOGENESIS IMPERFECTA	0.00728555	0.09017421902201939
DE BARSY SYNDROME	0.00728555	0.09017421902201939
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00728555	0.09017421902201939
HYPEREKPLEXIA 4; HKPX4	0.00728555	0.09017421902201939
DISTAL MONOSOMY 3P	0.00728555	0.09017421902201939
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00728555	0.09017421902201939
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00728555	0.09017421902201939
SCARF SYNDROME	0.00728555	0.09017421902201939
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00728555	0.09017421902201939
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00728555	0.09017421902201939
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00728555	0.09017421902201939
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.00728555	0.09017421902201939
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00728555	0.09017421902201939
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00728555	0.09017421902201939
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00728555	0.09017421902201939
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00728555	0.09017421902201939
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00728555	0.09017421902201939
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00724969	0.08973037504399033
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00724969	0.08973037504399033
OMODYSPLASIA 1; OMOD1	0.00724969	0.08973037504399033
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00724969	0.08973037504399033
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00724638	0.08968940673480806
NIEMANN-PICK DISEASE TYPE C	0.00724638	0.08968940673480806
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.08968940673480806
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00724638	0.08968940673480806
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00724638	0.08968940673480806
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.08968940673480806
MACHADO-JOSEPH DISEASE TYPE 1	0.00724638	0.08968940673480806
MACHADO-JOSEPH DISEASE TYPE 3	0.00724638	0.08968940673480806
MACHADO-JOSEPH DISEASE TYPE 2	0.00724638	0.08968940673480806
NEURALGIC AMYOTROPHY	0.00724638	0.08968940673480806
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00724638	0.08968940673480806
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00724638	0.08968940673480806
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00724638	0.08968940673480806
VICI SYNDROME	0.00724638	0.08968940673480806
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00724638	0.08968940673480806
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.08968940673480806
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.00724638	0.08968940673480806
LARYNGOTRACHEAL ANGIOMA	0.00724638	0.08968940673480806
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00724638	0.08968940673480806
MILD CANAVAN DISEASE	0.00724638	0.08968940673480806
SEVERE CANAVAN DISEASE	0.00724638	0.08968940673480806
16Q24.3 MICRODELETION SYNDROME	0.00704225	0.08716286264013232
17Q12 MICRODELETION SYNDROME	0.00704225	0.08716286264013232
RING CHROMOSOME 13 SYNDROME	0.00704225	0.08716286264013232
CHIME SYNDROME	0.00704225	0.08716286264013232
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00704225	0.08716286264013232
MACROCEPHALY/AUTISM SYNDROME	0.00704225	0.08716286264013232
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00704225	0.08716286264013232
HYPERLEXIA	0.00704225	0.08716286264013232
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00704225	0.08716286264013232
MENTAL RETARDATION, X-LINKED 9	0.00704225	0.08716286264013232
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00704225	0.08716286264013232
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00704225	0.08716286264013232
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.00704225	0.08716286264013232
AUSTRALIA ANTIGEN	0.00704225	0.08716286264013232
LEUKOCYTE ADHESION DEFICIENCY	0.00704225	0.08716286264013232
MENTAL RETARDATION, X-LINKED 88	0.00704225	0.08716286264013232
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00704225	0.08716286264013232
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00704225	0.08716286264013232
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00704225	0.08716286264013232
NANCE-HORAN SYNDROME	0.00704225	0.08716286264013232
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00704225	0.08716286264013232
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013232
MOEBIUS SYNDROME	0.00704225	0.08716286264013232
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00704225	0.08716286264013232
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00704225	0.08716286264013232
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00704225	0.08716286264013232
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00704225	0.08716286264013232
COWDEN SYNDROME	0.00704225	0.08716286264013232
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00671141	0.08306801206313472
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00671141	0.08306801206313472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313472
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	0.08306801206313472
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.00671141	0.08306801206313472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00671141	0.08306801206313472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313472
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313472
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00671141	0.08306801206313472
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313472
GRAFT VERSUS HOST DISEASE	0.00671141	0.08306801206313472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313472
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00671141	0.08306801206313472
HENNEKAM-BEEMER SYNDROME	0.00671141	0.08306801206313472
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.00671141	0.08306801206313472
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00671141	0.08306801206313472
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313472
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.00671141	0.08306801206313472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00671141	0.08306801206313472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313472
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	0.08306801206313472
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00671141	0.08306801206313472
MENTAL RETARDATION, X-LINKED 107; MRX107	0.00671141	0.08306801206313472
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.00671141	0.08306801206313472
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00671141	0.08306801206313472
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00671141	0.08306801206313472
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.00671141	0.08306801206313472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313472
KRABBE DISEASE	0.00671141	0.08306801206313472
FOLATE MALABSORPTION, HEREDITARY	0.00671141	0.08306801206313472
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00671141	0.08306801206313472
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00671141	0.08306801206313472
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00671141	0.08306801206313472
BETA-THALASSEMIA	0.00671141	0.08306801206313472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00671141	0.08306801206313472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313472
BEHCET SYNDROME	0.00671141	0.08306801206313472
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313472
DOORS SYNDROME	0.00671141	0.08306801206313472
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00671141	0.08306801206313472
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00671141	0.08306801206313472
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00671141	0.08306801206313472
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00671141	0.08306801206313472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.00671141	0.08306801206313472
HYPOPHOSPHATASIA, INFANTILE	0.00671141	0.08306801206313472
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00671141	0.08306801206313472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313472
HYPOPHOSPHATASIA	0.00671141	0.08306801206313472
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.00671141	0.08306801206313472
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313472
INFANTILE DYSTONIA-PARKINSONISM	0.00671141	0.08306801206313472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00671141	0.08306801206313472
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00671141	0.08306801206313472
ARGININOSUCCINIC ACIDURIA	0.00671141	0.08306801206313472
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313472
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.00671141	0.08306801206313472
JOUBERT SYNDROME 14	0.00671141	0.08306801206313472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313472
CITRULLINEMIA, CLASSIC	0.00671141	0.08306801206313472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.00671141	0.08306801206313472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.00671141	0.08306801206313472
AICARDI-GOUTIERES SYNDROME 7	0.00671141	0.08306801206313472
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.00671141	0.08306801206313472
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00671141	0.08306801206313472
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00671141	0.08306801206313472
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00671141	0.08306801206313472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.00671141	0.08306801206313472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00671141	0.08306801206313472
AICARDI-GOUTIERES SYNDROME 5	0.00671141	0.08306801206313472
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313472
COG4-CDG	0.00671141	0.08306801206313472
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313472
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313472
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.00671141	0.08306801206313472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00671141	0.08306801206313472
COG5-CDG	0.00671141	0.08306801206313472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00671141	0.08306801206313472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00671141	0.08306801206313472
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.00671141	0.08306801206313472
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00671141	0.08306801206313472
DIPHALLIA	0.005988240000000001	0.07411724102043324
3C SYNDROME	0.005988240000000001	0.07411724102043324
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.005988240000000001	0.07411724102043324
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.005988240000000001	0.07411724102043324
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005988240000000001	0.07411724102043324
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.005988240000000001	0.07411724102043324
OGDEN SYNDROME; OGDNS	0.005988240000000001	0.07411724102043324
SYNDROMIC DIARRHEA	0.005988240000000001	0.07411724102043324
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.005988240000000001	0.07411724102043324
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00549451	0.068006279300626
CAMPOMELIA, CUMMING TYPE	0.00549451	0.068006279300626
AXENFELD-RIEGER SYNDROME	0.00549451	0.068006279300626
DUANE RETRACTION SYNDROME	0.00549451	0.068006279300626
TRISOMY 18-LIKE SYNDROME	0.00549451	0.068006279300626
LAURENCE-MOON SYNDROME	0.00549451	0.068006279300626
ZIMMERMANN-LABAND SYNDROME	0.00549451	0.068006279300626
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.068006279300626
BOWEN-CONRADI SYNDROME	0.00549451	0.068006279300626
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.068006279300626
LARYNX ATRESIA	0.00549451	0.068006279300626
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00549451	0.068006279300626
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.068006279300626
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.068006279300626
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00549451	0.068006279300626
MCDONOUGH SYNDROME	0.00549451	0.068006279300626
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00549451	0.068006279300626
DISTAL TRISOMY 18Q	0.00549451	0.068006279300626
HEART-HAND SYNDROME TYPE 2	0.00549451	0.068006279300626
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00549451	0.068006279300626
MOSAIC TRISOMY 14	0.00549451	0.068006279300626
TRISOMY 12P	0.00549451	0.068006279300626
JOUBERT SYNDROME WITH RENAL DEFECT	0.00549451	0.068006279300626
NON-DISTAL TRISOMY 10Q	0.00549451	0.068006279300626
HALLERMANN-STREIFF SYNDROME	0.00549451	0.068006279300626
DISTAL MONOSOMY 10P	0.00549451	0.068006279300626
15Q26 OVERGROWTH SYNDROME	0.00549451	0.068006279300626
KALLMANN SYNDROME	0.00549451	0.068006279300626
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00549451	0.068006279300626
MONOSOMY 13Q14	0.00549451	0.068006279300626
MARSHALL-SMITH SYNDROME	0.00549451	0.068006279300626
ERYTHROKERATODERMIA VARIABILIS	0.00549451	0.068006279300626
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.068006279300626
HOLZGREVE SYNDROME	0.00549451	0.068006279300626
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00549451	0.068006279300626
SRD5A3-CDG	0.00549451	0.068006279300626
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.068006279300626
AUROCEPHALOSYNDACTYLY	0.00549451	0.068006279300626
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00549451	0.068006279300626
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00549451	0.068006279300626
CAMPOMELIC DYSPLASIA	0.00549451	0.068006279300626
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00549451	0.068006279300626
FRONTONASAL DYSPLASIA	0.00549451	0.068006279300626
THALIDOMIDE EMBRYOPATHY	0.00549451	0.068006279300626
TRISOMY 4P	0.00549451	0.068006279300626
TARP SYNDROME; TARPS	0.00549451	0.068006279300626
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.068006279300626
ACROCRANIOFACIAL DYSOSTOSIS	0.00549451	0.068006279300626
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.068006279300626
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00549451	0.068006279300626
ANTLEY-BIXLER SYNDROME	0.00549451	0.068006279300626
FLOATING-HARBOR SYNDROME	0.00549451	0.068006279300626
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00549451	0.068006279300626
PHENYLKETONURIA	0.00549451	0.068006279300626
6Q25 MICRODELETION SYNDROME	0.00549451	0.068006279300626
CAT-EYE SYNDROME	0.00549451	0.068006279300626
FACIOSCAPULOHUMERAL DYSTROPHY	0.00549451	0.068006279300626
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00549451	0.068006279300626
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00549451	0.068006279300626
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.068006279300626
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00549451	0.068006279300626
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.068006279300626
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00549451	0.068006279300626
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.068006279300626
NEUROFACIODIGITORENAL SYNDROME	0.00549451	0.068006279300626
MOSAIC TRISOMY 8	0.00549451	0.068006279300626
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00549451	0.068006279300626
RENAL AGENESIS, BILATERAL	0.00549451	0.068006279300626
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00549451	0.068006279300626
OROFACIODIGITAL SYNDROME TYPE 4	0.00549451	0.068006279300626
TETRASOMY X	0.00549451	0.068006279300626
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00546448	0.06763459400614154
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.00546448	0.06763459400614154
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00546448	0.06763459400614154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00546448	0.06763459400614154
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614154
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.06763459400614154
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00546448	0.06763459400614154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00546448	0.06763459400614154
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00546448	0.06763459400614154
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.00546448	0.06763459400614154
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614154
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00546448	0.06763459400614154
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00546448	0.06763459400614154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.00546448	0.06763459400614154
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614154
LEGIUS SYNDROME	0.00546448	0.06763459400614154
MUENKE SYNDROME	0.00546448	0.06763459400614154
NIJMEGEN BREAKAGE SYNDROME	0.00546448	0.06763459400614154
MICROTIA	0.00546448	0.06763459400614154
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00546448	0.06763459400614154
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00546448	0.06763459400614154
19P13.13 MICRODELETION SYNDROME	0.00546448	0.06763459400614154
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00546448	0.06763459400614154
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00546448	0.06763459400614154
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.06763459400614154
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.06763459400614154
MARDEN-WALKER SYNDROME	0.00546448	0.06763459400614154
IMMUNODEFICIENCY 61; IMD61	0.00546448	0.06763459400614154
SCLEROSTEOSIS 1; SOST1	0.00537634	0.06654367353142093
NEUROFIBROMATOSIS, TYPE II	0.00537634	0.06654367353142093
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.06654367353142093
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.06654367353142093
FAMILIAL THROMBOCYTOSIS	0.00537634	0.06654367353142093
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.06654367353142093
CAMURATI-ENGELMANN DISEASE	0.00537634	0.06654367353142093
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.06654367353142093
SNEDDON SYNDROME	0.00537634	0.06654367353142093
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.06654367353142093
TSH-SECRETING PITUITARY ADENOMA	0.00537634	0.06654367353142093
PONTIAC FEVER	0.00537634	0.06654367353142093
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.06654367353142093
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.06654367353142093
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.06654367353142093
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.06654367353142093
RAT-BITE FEVER	0.00537634	0.06654367353142093
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00537634	0.06654367353142093
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.06654367353142093
ROSAÏ-DORFMAN DISEASE	0.00537634	0.06654367353142093
RELAPSING FEVER	0.00537634	0.06654367353142093
SEVERE HEMOPHILIA A	0.00537634	0.06654367353142093
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.00537634	0.06654367353142093
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.00537634	0.06654367353142093
PROLACTINOMA	0.00537634	0.06654367353142093
LUJO HEMORRHAGIC FEVER	0.00537634	0.06654367353142093
CUTANEOUS MASTOCYTOMA	0.00537634	0.06654367353142093
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.00537634	0.06654367353142093
MAJEED SYNDROME	0.00537634	0.06654367353142093
LEPTOSPIROSIS	0.00537634	0.06654367353142093
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.06654367353142093
NON-FUNCTIONING PITUITARY ADENOMA	0.00537634	0.06654367353142093
COLD AGGLUTININ DISEASE	0.00537634	0.06654367353142093
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00537634	0.06654367353142093
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.06654367353142093
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.06654367353142093
LASSA FEVER	0.00537634	0.06654367353142093
GRANULOMATOSIS WITH POLYANGIITIS	0.00537634	0.06654367353142093
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00537634	0.06654367353142093
PAROXYSMAL COLD HEMOGLOBINURIA	0.00537634	0.06654367353142093
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.06654367353142093
HYPER-IGD SYNDROME	0.00537634	0.06654367353142093
AMERICAN TRYPANOSOMIASIS	0.00537634	0.06654367353142093
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.06654367353142093
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.06654367353142093
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.06654367353142093
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.06654367353142093
PITUICYTOMA	0.00537634	0.06654367353142093
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.06654367353142093
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00537634	0.06654367353142093
PRIMARY CILIARY DYSKINESIA	0.00537634	0.06654367353142093
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00537634	0.06654367353142093
HELLP SYNDROME	0.00537634	0.06654367353142093
CRANIOSYNOSTOSIS 2	0.00537634	0.06654367353142093
INTERNAL CAROTID AGENESIS	0.00537634	0.06654367353142093
HUGHES-STOVIN SYNDROME	0.00537634	0.06654367353142093
SYSTEMIC MASTOCYTOSIS	0.00537634	0.06654367353142093
HODGKIN LYMPHOMA	0.00537634	0.06654367353142093
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.06654367353142093
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.06654367353142093
THYMIC TUMOR	0.00537634	0.06654367353142093
PAPILLOMA OF CHOROID PLEXUS	0.00537634	0.06654367353142093
DENGUE FEVER	0.00537634	0.06654367353142093
PARKES WEBER SYNDROME	0.00537634	0.06654367353142093
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.06654367353142093
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.06654367353142093
SECONDARY POLYCYTHEMIA	0.00537634	0.06654367353142093
POLYCYTHEMIA VERA	0.00537634	0.06654367353142093
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00537634	0.06654367353142093
PINEOCYTOMA	0.00537634	0.06654367353142093
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.06654367353142093
ADENOHYPOPHYSITIS	0.00537634	0.06654367353142093
PITUITARY CARCINOMA	0.00537634	0.06654367353142093
OPTIC PATHWAY GLIOMA	0.00537634	0.06654367353142093
PERINEURAL CYST	0.00537634	0.06654367353142093
LHERMITTE-DUCLOS DISEASE	0.00537634	0.06654367353142093
PARIETAL FORAMINA	0.00537634	0.06654367353142093
CARNEY TRIAD	0.00537634	0.06654367353142093
EBOLA HEMORRHAGIC FEVER	0.00537634	0.06654367353142093
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.00537634	0.06654367353142093
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00537634	0.06654367353142093
CROUZON DISEASE	0.00537634	0.06654367353142093
MARBURG HEMORRHAGIC FEVER	0.00537634	0.06654367353142093
SOLAR URTICARIA	0.00537634	0.06654367353142093
HYDROXYKYNURENINURIA	0.00537634	0.06654367353142093
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00537634	0.06654367353142093
EPISODIC ATAXIA, TYPE 3	0.00537634	0.06654367353142093
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.06654367353142093
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.06654367353142093
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.06654367353142093
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.06654367353142093
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.06654367353142093
MARSILI SYNDROME; MARSIS	0.00537634	0.06654367353142093
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.06654367353142093
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.06654367353142093
HEMANGIOBLASTOMA	0.00537634	0.06654367353142093
EPISODIC ATAXIA TYPE 1	0.00537634	0.06654367353142093
SOTOS SYNDROME 2	0.00492611	0.06097111708334441
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.06097111708334441
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00492611	0.06097111708334441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00492611	0.06097111708334441
GENIOSPASM 1; GSM1	0.00492611	0.06097111708334441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00492611	0.06097111708334441
DYSTONIA-APHONIA SYNDROME	0.00492611	0.06097111708334441
LAMB-SHAFFER SYNDROME	0.00492611	0.06097111708334441
PANIC DISORDER 1	0.00492611	0.06097111708334441
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.06097111708334441
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.06097111708334441
ALAZAMI SYNDROME; ALAZS	0.00492611	0.06097111708334441
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.06097111708334441
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00473934	0.058659440012053636
11P15.4 MICRODUPLICATION SYNDROME	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00473934	0.058659440012053636
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00473934	0.058659440012053636
JUVENILE MYOCLONIC EPILEPSY	0.00473934	0.058659440012053636
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00473934	0.058659440012053636
JAWAD SYNDROME	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00473934	0.058659440012053636
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00473934	0.058659440012053636
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.058659440012053636
MENTAL RETARDATION, X-LINKED 102	0.00473934	0.058659440012053636
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00473934	0.058659440012053636
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00473934	0.058659440012053636
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00473934	0.058659440012053636
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.058659440012053636
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.00473934	0.058659440012053636
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.058659440012053636
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00473934	0.058659440012053636
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00473934	0.058659440012053636
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.058659440012053636
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00473934	0.058659440012053636
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00473934	0.058659440012053636
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00473934	0.058659440012053636
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.058659440012053636
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.058659440012053636
MENTAL RETARDATION, X-LINKED 99	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00473934	0.058659440012053636
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.058659440012053636
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00473934	0.058659440012053636
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00473934	0.058659440012053636
PITT-HOPKINS SYNDROME	0.00473934	0.058659440012053636
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00473934	0.058659440012053636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.00473934	0.058659440012053636
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.00473934	0.058659440012053636
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.00473934	0.058659440012053636
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00473934	0.058659440012053636
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.05625963775605659
CHRONIC GRAFT VERSUS HOST DISEASE	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.05625963775605659
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.05625963775605659
BLAU SYNDROME	0.00454545	0.05625963775605659
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.05625963775605659
BRADYOPSIA	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.05625963775605659
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.05625963775605659
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.05625963775605659
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.05625963775605659
ALACRIMA, CONGENITAL	0.00454545	0.05625963775605659
ECTODERMAL DYSPLASIA SYNDROME	0.00454545	0.05625963775605659
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.05625963775605659
HERMANSKY-PUDLAK SYNDROME	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 2	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 4	0.00454545	0.05625963775605659
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.05625963775605659
NEOVASCULAR GLAUCOMA	0.00454545	0.05625963775605659
OLIGOCONE TRICHROMACY	0.00454545	0.05625963775605659
MACULAR CORNEAL DYSTROPHY	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.05625963775605659
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM	0.00454545	0.05625963775605659
SJÖGREN-LARSSON SYNDROME	0.00454545	0.05625963775605659
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00454545	0.05625963775605659
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00454545	0.05625963775605659
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.05625963775605659
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.05625963775605659
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00454545	0.05625963775605659
CORNEAL FLECK DYSTROPHY	0.00454545	0.05625963775605659
ALSTROM SYNDROME; ALMS	0.00454545	0.05625963775605659
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.05625963775605659
MUCOLIPIDOSIS IV; ML4	0.00454545	0.05625963775605659
TYROSINEMIA TYPE 2	0.00454545	0.05625963775605659
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00454545	0.05625963775605659
ALACRIMA	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.05625963775605659
ACHROMATOPSIA 7; ACHM7	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 17	0.00454545	0.05625963775605659
KID SYNDROME	0.00454545	0.05625963775605659
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00454545	0.05625963775605659
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.05625963775605659
OCULAR ALBINISM	0.00454545	0.05625963775605659
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.05625963775605659
REACTIVE ARTHRITIS	0.00454545	0.05625963775605659
ACHROMATOPSIA	0.00454545	0.05625963775605659
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.05625963775605659
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.05625963775605659
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.05625963775605659
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.05625963775605659
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 79	0.00454545	0.05625963775605659
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00454545	0.05625963775605659
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.05625963775605659
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.05625963775605659
RETINAL CONE DYSTROPHY 3B	0.00454545	0.05625963775605659
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 10	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.05625963775605659
RETINAL CONE DYSTROPHY 4	0.00454545	0.05625963775605659
STEVENS-JOHNSON SYNDROME	0.00454545	0.05625963775605659
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.05625963775605659
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.05625963775605659
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00454545	0.05625963775605659
CONE DYSTROPHY 4	0.00454545	0.05625963775605659
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.05625963775605659
CONE DYSTROPHY 3	0.00454545	0.05625963775605659
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS 16	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 16	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.05625963775605659
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.05625963775605659
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.05625963775605659
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00454545	0.05625963775605659
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.05625963775605659
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.05625963775605659
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.05625963775605659
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.00454545	0.05625963775605659
IRVAN SYNDROME	0.00454545	0.05625963775605659
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.05625963775605659
MUCOLIPIDOSIS TYPE IV	0.00454545	0.05625963775605659
JALILI SYNDROME	0.00454545	0.05625963775605659
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00454545	0.05625963775605659
LEUKONYCHIA TOTALIS	0.00454545	0.05625963775605659
FLOTCH SYNDROME	0.00454545	0.05625963775605659
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.05625963775605659
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.05625963775605659
BLUE CONE MONOCHROMATISM	0.00454545	0.05625963775605659
COGAN SYNDROME	0.00454545	0.05625963775605659
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.05625963775605659
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00454545	0.05625963775605659
CONE ROD DYSTROPHY	0.00454545	0.05625963775605659
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.05625963775605659
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605659
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.05625963775605659
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM	0.00454545	0.05625963775605659
ALBINISM, OCULAR, TYPE I	0.00454545	0.05625963775605659
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00454545	0.05625963775605659
X-LINKED RECESSIVE OCULAR ALBINISM	0.00454545	0.05625963775605659
HIDROTIC ECTODERMAL DYSPLASIA	0.00454545	0.05625963775605659
AMOEBIC KERATITIS	0.00454545	0.05625963775605659
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.05625963775605659
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.05625963775605659
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00454545	0.05625963775605659
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.05500942358369977
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.05500942358369977
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.05500942358369977
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.05500942358369977
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.05500942358369977
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00444444	0.05500942358369977
TRIMETHYLAMINURIA	0.00444444	0.05500942358369977
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.05500942358369977
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.05500942358369977
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.05500942358369977
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00444444	0.05500942358369977
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.05500942358369977
GLUCAGONOMA	0.00444444	0.05500942358369977
ACERULOPLASMINEMIA	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00444444	0.05500942358369977
GAUCHER DISEASE	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA TYPE 42	0.00444444	0.05500942358369977
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.05500942358369977
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369977
MACS SYNDROME	0.0042734999999999995	0.05289367652278823
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0042734999999999995	0.05289367652278823
ROIFMAN-CHITAYAT SYNDROME	0.0042734999999999995	0.05289367652278823
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.05289367652278823
ZIMMERMANN-LABAND SYNDROME 1	0.0042734999999999995	0.05289367652278823
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0042734999999999995	0.05289367652278823
BRANCHIOSKELETOGENITAL SYNDROME	0.0042734999999999995	0.05289367652278823
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0042734999999999995	0.05289367652278823
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0042734999999999995	0.05289367652278823
COHEN-GIBSON SYNDROME; COGIS	0.0042734999999999995	0.05289367652278823
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0042734999999999995	0.05289367652278823
IMMUNODEFICIENCY 49; IMD49	0.0042734999999999995	0.05289367652278823
MEIER-GORLIN SYNDROME 6; MGORS6	0.0042734999999999995	0.05289367652278823
PELGER-HUET ANOMALY; PHA	0.0042734999999999995	0.05289367652278823
SMITH-KINGSMORE SYNDROME; SKS	0.0042734999999999995	0.05289367652278823
ICF SYNDROME	0.0042734999999999995	0.05289367652278823
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0042734999999999995	0.05289367652278823
CRANIOFACIAL DYSSYNOSTOSIS	0.0042734999999999995	0.05289367652278823
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0042734999999999995	0.05289367652278823
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0042734999999999995	0.05289367652278823
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.0042734999999999995	0.05289367652278823
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0042734999999999995	0.05289367652278823
RIN2 SYNDROME	0.0042734999999999995	0.05289367652278823
PROGEROID SYNDROME, PETTY TYPE	0.0042734999999999995	0.05289367652278823
GAPO SYNDROME	0.0042734999999999995	0.05289367652278823
3MC SYNDROME	0.0042734999999999995	0.05289367652278823
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0042734999999999995	0.05289367652278823
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.05289367652278823
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.05289367652278823
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.05289367652278823
MONOSOMY 9Q22.3	0.0042734999999999995	0.05289367652278823
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0042734999999999995	0.05289367652278823
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.05289367652278823
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0042734999999999995	0.05289367652278823
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0042734999999999995	0.05289367652278823
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0042734999999999995	0.05289367652278823
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00301205	0.03728054249923115
ULNAR-MAMMARY SYNDROME; UMS	0.00301205	0.03728054249923115
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00301205	0.03728054249923115
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00301205	0.03728054249923115
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00301205	0.03728054249923115
LAMBERT SYNDROME	0.00301205	0.03728054249923115
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00301205	0.03728054249923115
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.00301205	0.03728054249923115
RHINY	0.00301205	0.03728054249923115
RUVALCABA SYNDROME	0.00301205	0.03728054249923115
SIMOSA CRANIOFACIAL SYNDROME	0.00301205	0.03728054249923115
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00301205	0.03728054249923115
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00301205	0.03728054249923115
LAMBERT SYNDROME	0.00301205	0.03728054249923115
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.00301205	0.03728054249923115
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00301205	0.03728054249923115
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00301205	0.03728054249923115
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00301205	0.03728054249923115
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00301205	0.03728054249923115
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00301205	0.03728054249923115
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00301205	0.03728054249923115
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00301205	0.03728054249923115
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00301205	0.03728054249923115
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00301205	0.03728054249923115
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00301205	0.03728054249923115
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00301205	0.03728054249923115
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00301205	0.03728054249923115
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.03728054249923115
OSTEOGLOSPHONIC DYSPLASIA	0.00301205	0.03728054249923115
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00301205	0.03728054249923115
HERNIA, DOUBLE INGUINAL	0.00301205	0.03728054249923115
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00301205	0.03728054249923115
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.00301205	0.03728054249923115
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00301205	0.03728054249923115
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.00301205	0.03728054249923115
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00301205	0.03728054249923115
EXSTROPHY OF BLADDER	0.00301205	0.03728054249923115
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00301205	0.03728054249923115
MUCOLIPIDOSIS TYPE III	0.00301205	0.03728054249923115
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00301205	0.03728054249923115
MICROSPHEROPHAKIA WITH HERNIA	0.00301205	0.03728054249923115
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00301205	0.03728054249923115
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00301205	0.03728054249923115
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00301205	0.03728054249923115
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00301205	0.03728054249923115
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00301205	0.03728054249923115
WIDOW'S PEAK SYNDROME	0.00301205	0.03728054249923115
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, TYPE VI	0.00301205	0.03728054249923115
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00301205	0.03728054249923115
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.00301205	0.03728054249923115
DIAPHANOSPONDYLODYSOSTOSIS	0.00301205	0.03728054249923115
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00301205	0.03728054249923115
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00301205	0.03728054249923115
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00301205	0.03728054249923115
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00301205	0.03728054249923115
OSTEOGENESIS IMPERFECTA, TYPE X	0.00301205	0.03728054249923115
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00301205	0.03728054249923115
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00301205	0.03728054249923115
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00301205	0.03728054249923115
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00301205	0.03728054249923115
MORQUIO SYNDROME A	0.00301205	0.03728054249923115
268650 RUDIGER SYNDROME	0.00301205	0.03728054249923115
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00301205	0.03728054249923115
MARDEN-WALKER SYNDROME	0.00301205	0.03728054249923115
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00301205	0.03728054249923115
GM1 GANGLIOSIDOSIS	0.00301205	0.03728054249923115
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00301205	0.03728054249923115
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00301205	0.03728054249923115
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00301205	0.03728054249923115
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.03728054249923115
BRUCK SYNDROME 2	0.00301205	0.03728054249923115
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00301205	0.03728054249923115
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00301205	0.03728054249923115
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00301205	0.03728054249923115
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00301205	0.03728054249923115
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00301205	0.03728054249923115
SHORT SYNDROME	0.00301205	0.03728054249923115
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00301205	0.03728054249923115
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00301205	0.03728054249923115
SHORT SYNDROME	0.00301205	0.03728054249923115
NEURAMINIDASE DEFICIENCY	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00301205	0.03728054249923115
17P13.3 MICRODUPLICATION SYNDROME	0.00301205	0.03728054249923115
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.03728054249923115
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00301205	0.03728054249923115
RUVALCABA SYNDROME	0.00301205	0.03728054249923115
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00301205	0.03728054249923115
NOONAN SYNDROME 11; NS11	0.00297619	0.03683669852120209
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.00297619	0.03683669852120209
THANATOPHORIC DYSPLASIA TYPE 1	0.00297619	0.03683669852120209
8P11.2 DELETION SYNDROME	0.00297619	0.03683669852120209
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00297619	0.03683669852120209
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00297619	0.03683669852120209
AORTIC VALVE DISEASE 3; AOVD3	0.00297619	0.03683669852120209
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00297619	0.03683669852120209
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00297619	0.03683669852120209
OROTIC ACIDURIA	0.00297619	0.03683669852120209
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.03683669852120209
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00297619	0.03683669852120209
KAPUR-TORIELLO SYNDROME	0.00297619	0.03683669852120209
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00297619	0.03683669852120209
JOHANSON-BLIZZARD SYNDROME; JBS	0.00297619	0.03683669852120209
HYPOPLASTIC LEFT HEART SYNDROME	0.00297619	0.03683669852120209
MCKUSICK-KAUFMAN SYNDROME	0.00297619	0.03683669852120209
TRANSALDOLASE DEFICIENCY	0.00297619	0.03683669852120209
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.03683669852120209
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00297619	0.03683669852120209
JUVENILE POLYPOSIS OF INFANCY	0.00297619	0.03683669852120209
FAMILIAL CUTANEOUS COLLAGENOMA	0.00297619	0.03683669852120209
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00297619	0.03683669852120209
CATEL-MANZKE SYNDROME	0.00297619	0.03683669852120209
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00297619	0.03683669852120209
LETHAL KNIEST-LIKE DYSPLASIA	0.00297619	0.03683669852120209
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00297619	0.03683669852120209
ZECHI-CEIDE SYNDROME	0.00297619	0.03683669852120209
ALAGILLE SYNDROME 1; ALGS1	0.00297619	0.03683669852120209
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.00297619	0.03683669852120209
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00297619	0.03683669852120209
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00297619	0.03683669852120209
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00297619	0.03683669852120209
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.00297619	0.03683669852120209
MEGALENCEPHALY	0.00297619	0.03683669852120209
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00297619	0.03683669852120209
MCDONOUGH SYNDROME	0.00297619	0.03683669852120209
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00297619	0.03683669852120209
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00297619	0.03683669852120209
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00297619	0.03683669852120209
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00297619	0.03683669852120209
LYMPHATIC MALFORMATION 7; LMPHM7	0.00297619	0.03683669852120209
20P12.3 MICRODELETION SYNDROME	0.00297619	0.03683669852120209
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00297619	0.03683669852120209
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00297619	0.03683669852120209
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00297619	0.03683669852120209
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.00297619	0.03683669852120209
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00297619	0.03683669852120209
SPONDYLOOCULAR SYNDROME; SOS	0.00297619	0.03683669852120209
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00297619	0.03683669852120209
CONGENITAL PULMONARY VALVE STENOSIS	0.00297619	0.03683669852120209
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00297619	0.03683669852120209
FRONTOOCULAR SYNDROME	0.00297619	0.03683669852120209
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00297619	0.03683669852120209
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00297619	0.03683669852120209
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00297619	0.03683669852120209
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00297619	0.03683669852120209
NOONAN SYNDROME 8; NS8	0.00297619	0.03683669852120209
THANATOPHORIC DYSPLASIA TYPE 2	0.00297619	0.03683669852120209
ELLIS-VAN CREVELD SYNDROME	0.00297619	0.03683669852120209
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.00297619	0.03683669852120209
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00297619	0.03683669852120209
NOONAN SYNDROME 7; NS7	0.00297619	0.03683669852120209
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00297619	0.03683669852120209
EBSTEIN ANOMALY	0.00297619	0.03683669852120209
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00297619	0.03683669852120209
ALAGILLE SYNDROME 2	0.00297619	0.03683669852120209
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00297619	0.03683669852120209
NOONAN SYNDROME 3; NS3	0.00297619	0.03683669852120209
NOONAN SYNDROME 5; NS5	0.00297619	0.03683669852120209
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00297619	0.03683669852120209
611961 STEVENSON-CAREY SYNDROME	0.00297619	0.03683669852120209
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.00297619	0.03683669852120209
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00297619	0.03683669852120209
DIAMOND-BLACKFAN ANEMIA 4	0.00297619	0.03683669852120209
KLIPPEL-TRÉNAUNAY SYNDROME	0.00297619	0.03683669852120209
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00297619	0.03683669852120209
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00297619	0.03683669852120209
ATRIAL SEPTAL DEFECT 5	0.00297619	0.03683669852120209
XK APROSENCEPHALY SYNDROME	0.00297619	0.03683669852120209
HADZISELIMOVIC SYNDROME	0.00297619	0.03683669852120209
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00297619	0.03683669852120209
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00297619	0.03683669852120209
BARDET-BIEDL SYNDROME 2	0.00297619	0.03683669852120209
PRUNE BELLY SYNDROME	0.00297619	0.03683669852120209
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00297619	0.03683669852120209
SHASHI-PENA SYNDROME; SHAPNS	0.00297619	0.03683669852120209
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.00297619	0.03683669852120209
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00297619	0.03683669852120209
DIAMOND-BLACKFAN ANEMIA 16	0.00297619	0.03683669852120209
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00297619	0.03683669852120209
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00297619	0.03683669852120209
KABUKI SYNDROME 1	0.00297619	0.03683669852120209
JACOBSEN SYNDROME	0.00297619	0.03683669852120209
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00297619	0.03683669852120209
ALAGILLE SYNDROME	0.00297619	0.03683669852120209
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00297619	0.03683669852120209
RECOMBINANT 8 SYNDROME	0.00297619	0.03683669852120209
AL KAISSI SYNDROME; ALKAS	0.00297619	0.03683669852120209
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00297619	0.03683669852120209
THANATOPHORIC DYSPLASIA	0.00297619	0.03683669852120209
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00297619	0.03683669852120209
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00297619	0.03683669852120209
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.03683669852120209
WAARDENBURG SYNDROME TYPE 3	0.00297619	0.03683669852120209
SIFRIM-HITZ-WEISS SYNDROME	0.00297619	0.03683669852120209
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00297619	0.03683669852120209
COFFIN-SIRIS SYNDROME 5	0.00297619	0.03683669852120209
GENITOPATELLAR SYNDROME	0.00297619	0.03683669852120209
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00297619	0.03683669852120209
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00297619	0.03683669852120209
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00297619	0.03683669852120209
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00297619	0.03683669852120209
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00297619	0.03683669852120209
CONGENITAL RUBELLA SYNDROME	0.00297619	0.03683669852120209
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00297619	0.03683669852120209
ELLIS VAN CREVELD SYNDROME	0.00297619	0.03683669852120209
TARP SYNDROME	0.00297619	0.03683669852120209
OCULOECTODERMAL SYNDROME; OES	0.00297619	0.03683669852120209
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00297619	0.03683669852120209
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00297619	0.03683669852120209
LYMPHEDEMA, HEREDITARY, III	0.00297619	0.03683669852120209
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00297619	0.03683669852120209
CHROMOSOME 15Q14 DELETION SYNDROME	0.00297619	0.03683669852120209
PENILE AGENESIS	0.00297619	0.03683669852120209
FETAL TRIMETHADIONE SYNDROME	0.00297619	0.03683669852120209
